ciprofloxacin has been researched along with Acute Disease in 242 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The study aimed to compare the efficacy and safety of Canephron N and ciprofloxacin as monotherapy in the management of mild forms of acute uncomplicated cystitis in women of working age." | 9.27 | [Comparative assessment of Canephron N and ciprofloxacin as monotherapy of acute uncomplicated cystitis in women]. ( Bunova, NE; Davidov, MI, 2018) |
| "To determine whether cefpodoxime is noninferior to ciprofloxacin for treatment of acute cystitis." | 9.16 | Cefpodoxime vs ciprofloxacin for short-course treatment of acute uncomplicated cystitis: a randomized trial. ( Hooton, TM; Roberts, PL; Stapleton, AE, 2012) |
| "In a prospective, non-inferiority trial undertaken at 21 centres of infectious diseases in Sweden, women (aged ≥18 years) who were not pregnant and had a presumptive diagnosis of acute pyelonephritis were randomly assigned to oral treatment with ciprofloxacin 500 mg twice daily for 7 days or 14 days." | 9.16 | Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. ( Ekman, GS; Hermansson, AB; Kahlmeter, G; Kuylenstierna, N; Lannergård, A; Otto, G; Sandberg, T; Settergren, B; Skoog, G, 2012) |
| "This multicentre, double-blind study was undertaken to demonstrate non-inferiority of once-daily oral moxifloxacin compared with combination therapy in the management of acute, uncomplicated pelvic inflammatory disease (PID)." | 9.14 | A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease. ( Heystek, M; Ross, JD, 2009) |
| "Furagin (a nitrofurantoin analogue) has the same efficacy in treating acute cystitis as ciprofloxacin, however the duration of therapy is longer." | 9.13 | Ciprofloxacin and furagin in acute cystitis: comparison of early immune and microbiological results. ( Borkowski, A; Dybowski, B; Gromadzka-Ostrowska, J; Jabłońska, O; Radziszewski, P, 2008) |
| "A clinical study was conducted to compare the efficacy and safety of levofloxacin 750 mg once daily for 5 days to ciprofloxacin twice daily for 10 days for the treatment of complicated urinary tract infections (cUTI) or acute pyelonephritis (AP)." | 9.13 | A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis. ( Fisher, AC; Kahn, JB; Kaul, S; Khashab, M; Peterson, J, 2008) |
| "A double-blind, noninferiority trial was conducted to establish the safety and efficacy of a once-daily, 5-day course of levofloxacin 750 mg compared to a twice-daily, 10-day course of ciprofloxacin in complicated urinary tract infections (cUTI) and acute pyelonephritis (AP)." | 9.12 | A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis. ( Brown, P; Fisher, AC; Kahn, JB; Kaul, S; Khashab, M; Klausner, HA; Peterson, J, 2007) |
| "We assessed the efficacy and safety of 1,000 mg extended release ciprofloxacin orally once daily vs conventional 500 mg ciprofloxacin orally twice daily, each for 7 to 14 days, in patients with a complicated urinary tract infection (cUTI) or acute uncomplicated pyelonephritis (AUP)." | 9.11 | Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis. ( Church, DA; Klimberg, IW; Kowalsky, SF; Nicolle, LE; Song, J; Talan, DA, 2004) |
| "Randomized, patient-masked, parallel-group, multicenter trial of topical otic ciprofloxacin/dexamethasone versus topical ciprofloxacin alone in 201 children aged 6 months to 12 years with acute otitis media with tympanostomy tubes (AOMT) of less than or equal to 3 weeks' duration and visible otorrhea." | 9.10 | Topical ciprofloxacin/dexamethasone is superior to ciprofloxacin alone in pediatric patients with acute otitis media and otorrhea through tympanostomy tubes. ( Anon, JB; Conroy, PJ; Dupre, SJ; Hogg, G; Krueger, KA; Moe, RD; Potts, S; Roland, PS; Stroman, DW; Wall, GM, 2003) |
| "A multinational, multicentre, randomized, prospective, parallel-group study compared treatment with ciprofloxacin administered as an oral suspension (500 mg twice daily for 7 days) with co-amoxiclav tablets (625 mg three times daily for 7 days) in patients suffering from acute exacerbations of chronic bronchitis (AECB)." | 9.09 | The efficacy and safety of a new ciprofloxacin suspension compared with co-amoxiclav tablets in the treatment of acute exacerbations of chronic bronchitis. ( Berrisoul, F; Kearsley, N; Kubin, R; Kuss, A; Read, RC; Torres, A, 1999) |
| "Ciprofloxacin 500 mg orally twice daily was compared to pivampicillin 700 mg orally twice daily for 10 days in 172 men (41-85 years) with acute epididymitis." | 9.09 | [Ciprofloxacin and pivampicillin in acute epididymitis in men above the age of 40 years]. ( Eickhoff, JH; Frimodt-Møller, C; Frimodt-Møller, N; Walter, S, 2000) |
| "To evaluate the efficacy and safety of a suspension formulation of ciprofloxacin in the treatment of acute invasive diarrhea in infants and children." | 9.09 | Oral ciprofloxacin vs. intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children. ( Dagan, R; Janco, J; Leibovitz, E; Piglansky, L; Press, J; Reinhart, H; Yagupsky, P; Yaniv, I, 2000) |
| "To investigate the effects of an intravenous injection of tobramycin (T) in female patients with acute uncomplicated pyelonephritis treated with ciprofloxacin (CIP) (500 mg bid per os)." | 9.09 | [Acute pyelonephritis. Randomized multicenter double-blind study comparing ciprofloxacin with combined ciprofloxacin and tobramycin]. ( Baron, D; Bonnieux, J; Bourrier, P; Le Conte, P; Lebrin, P; Merit, JB; Potel, G; Simon, N, 2001) |
| "Metronidazole is effective for the treatment of acute pouchitis after ileal pouch-anal anastomosis, but it has not been directly compared with other antibiotics." | 9.09 | A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. ( Achkar, JP; Bambrick, ML; Bevins, CL; Brzezinski, A; Fazio, VW; Lashner, BA; Ormsby, AH; Remzi, FH; Seidner, DL; Shen, B, 2001) |
| "One hundred consecutive patients with acute suppurative cholangitis were randomized in a prospective, controlled clinical trial to receive either ciprofloxacin (200 mg bd iv) or triple therapy comprising ceftazidime (1 g bd iv), ampicillin (500 mg qds iv) and metronidazole (500 mg tds iv); 46 and 44 patients in the ciprofloxacin and triple therapy groups respectively were suitable for inclusion in the analysis of efficacy." | 9.08 | Intravenous ciprofloxacin as treatment for patients with acute suppurative cholangitis: a randomized, controlled clinical trial. ( Cheng, AF; Chung, SC; Co, AL; Leung, JW; Li, AK; Lyon, DJ; Suen, R; Sung, JJ, 1995) |
| "We compare the bacteriological and clinical efficacy of rufloxacin and ciprofloxacin in patients with acute uncomplicated pyelonephritis." | 9.08 | Rufloxacin once daily versus ciprofloxacin twice daily in the treatment of patients with acute uncomplicated pyelonephritis. ( Bach, D; Cesana, M; Hübner, A; Plétan, Y; van Breukelen, G; van den Berg-Segers, A, 1995) |
| "A multicentric double-blind double-placebo randomized trial was conducted to compare the effectiveness and safety of ciprofloxacin versus pefloxacin given in a single oral dose in female out-patients with acute cystitis." | 9.08 | [Efficacy of single dose of ciprofloxacin and pefloxacin in the treatment of female acute cystitis]. ( Guibert, J, 1995) |
| "The aim of this study was to compare the efficacy of single-dose pefloxacin 400 mg and ciprofloxacin 250 mg in the treatment of acute uncomplicated gonococcal urethritis in males." | 9.08 | Comparing the efficacy of pefloxacin and ciprofloxacin in the treatment of acute uncomplicated gonococcal urethritis in males. ( Chan, RK; Cheong, LL; Goh, CL; Leow, YH; Nadarajah, M, 1995) |
| "/oral ciprofloxacin monotherapy offers a safe and efficacious alternative to standard parenteral therapy for acute pulmonary exacerbations in pediatric cystic fibrosis patients." | 9.08 | Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group. ( Church, DA; Echols, RM; Haverstock, DC; Kanga, JF; Kuhn, RJ; Painter, BG; Perroncel, RY; Rubio, TT; Spohn, WA; Stevens, JC; Thurberg, BE, 1997) |
| " This study examined the disposition of sequentially administered intravenous and oral ciprofloxacin, as well as provided dosing recommendations, for the treatment of acute pulmonary exacerbations in pediatric cystic fibrosis patients." | 9.08 | Pharmacokinetic disposition of sequential intravenous/oral ciprofloxacin in pediatric cystic fibrosis patients with acute pulmonary exacerbation. ( Church, DA; Echols, RM; Kuhn, RJ; Lettieri, JT; Miles, MV; Rubio, TT, 1997) |
| "A randomized, prospective, double-blind, double-dummy, multicenter study investigated the efficacy and safety of 10 days of oral therapy with grepafloxacin at 400 mg once daily, grepafloxacin at 600 mg once daily, or ciprofloxacin at 500 mg twice daily in 624 patients with acute bacterial exacerbations of chronic bronchitis." | 9.08 | Efficacy and safety of a 10-day course of 400 or 600 milligrams of grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: comparison with a 10-day course of 500 milligrams of ciprofloxacin twice daily. ( Breisch, S; Chodosh, S; Lakshminarayan, S; Swarz, H, 1998) |
| "We conducted a prospective, randomized, double-blind pilot study of oral ciprofloxacin (500 mg twice daily) versus cefuroxime axetil (250 mg twice daily) for 2 to 3 weeks in the treatment of adult patients with a clinical diagnosis of acute bacterial maxillary sinus infections or acute exacerbation of chronic bacterial sinusitis." | 9.08 | Ciprofloxacin versus cefuroxime axetil in the treatment of adult patients with acute bacterial sinusitis. ( Echols, RM; Heyd, A; Klein, GL; Whalen, E, 1998) |
| "To evaluate, in two randomized, multicenter trials, levofloxacin compared with ciprofloxacin and lomefloxacin for efficacy and safety in treating acute pyelonephritis." | 9.08 | Levofloxacin versus ciprofloxacin versus lomefloxacin in acute pyelonephritis. ( Callery-D'Amico, S; Fowler, CL; Kim, SS; Klimberg, IN; Richard, GA, 1998) |
| "In a prospective, multicenter, double-blind study, the interval to clinical relapse in patients with acute bacterial exacerbations of chronic bronchitis from whom a pretherapy pathogen was isolated was compared following treatment with ciprofloxacin or cefuroxime axetil." | 9.08 | Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group. ( Aneiro, L; Chodosh, S; Drehobl, M; Farkas, S; Kowalsky, S; McCarty, J; Shan, M; Tosiello, R, 1998) |
| "The role of ciprofloxacin and trimethoprim-sulfamethoxazole (TMP-SMZ) was evaluated in empiric treatment of uncomplicated Salmonella enteritis in a comparative, double-blind trial." | 9.07 | Ciprofloxacin and trimethoprim-sulfamethoxazole versus placebo in acute uncomplicated Salmonella enteritis: a double-blind trial. ( Bella, F; Cobo, E; Espejo, E; Freixas, N; Garau, J; García-Restoy, E; Lite, J; Sánchez, C; Sánchez, P; Simó, M, 1993) |
| "A prospective, randomised trial was undertaken to compare the efficacy of ciprofloxacin and netilmicin for the treatment of acute pyelonephritis." | 9.07 | Comparison of ciprofloxacin with netilmicin for the treatment of acute pyelonephritis. ( Bailey, RR; Lynn, KL; Peddie, BA; Robson, RA; Smith, A, 1992) |
| "A prospective, randomized, controlled, non-blind clinical trial was conducted to compare the efficacy of monotherapy with ciprofloxacin with that of a combination of clindamycin plus gentamicin in the treatment of patients with acute pelvic inflammatory disease." | 9.06 | Efficacy of single-agent therapy for the treatment of acute pelvic inflammatory disease with ciprofloxacin. ( Crombleholme, WR; Luft, J; Ohm-Smith, M; Schachter, J; Sweet, RL; Whidden, R, 1989) |
| "In a double-blind, randomized, placebo-controlled trial 50 adult patients with acute diarrhea received either 500 mg ciprofloxacin b." | 9.06 | Ciprofloxacin in the treatment of acute bacterial diarrhea: a double blind study. ( Diridl, G; Pichler, H; Wolf, D, 1986) |
| "Oral ciprofloxacin was used at doses ranging from 500 mg to 1500 mg twice daily for 15 to 476 (mean 139) days for treatment of acute or chronic osteomyelitis in 38 patients, and acute arthritis in two." | 9.06 | Therapy of acute and chronic gram-negative osteomyelitis with ciprofloxacin. Report from a Swedish Study Group. ( , 1988) |
| "Fifty-six patients receiving remission induction treatment for acute leukemia were studied in a randomized trial comparing ciprofloxacin with trimethoprim-sulfamethoxazole plus colistin for prevention of infections." | 9.06 | Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin. ( Dekker, AW; Rozenberg-Arska, M; Verhoef, J, 1987) |
| "The objectives of this study were to investigate risk factors and the incidence of ciprofloxacin resistance and extended-spectrum beta-lactamases (ESBL) in patients with acute bacterial prostatitis (ABP)." | 7.83 | Risk Factor Analysis of Ciprofloxacin-Resistant and Extended Spectrum Beta-Lactamases Pathogen-Induced Acute Bacterial Prostatitis in Korea. ( Lee, DG; Lee, SH; Lee, Y; Yoo, KH, 2016) |
| "Ciprofloxacin is considered to be a safe and effective treatment for acute infectious colitis." | 7.80 | Acute pancreatitis secondary to ciprofloxacin therapy in patients with infectious colitis. ( Cheung, DY; Cho, HJ; Cho, SH; Kim, JI; Kim, JK; Kim, SS; Lee, HJ; Sung, HY, 2014) |
| " In this study, among the patients of brucellosis, whose diseases were recently diagnosed, 50 patients, receiving one of the two common authentic regimens of doxycycline plus rifampin for eight weeks or ciprofloxacin plus rifampin for six weeks, were selected." | 7.77 | A comparison between doxycycline-rifampin and ciprofloxacin-rifampin regimens in the treatment of acute Brucellosis. ( Hassani, M; Nozadi, MS; Taghvaee, MR, 2011) |
| "To compare treatment failure rates for the two major acute otitis externa (AOE) pathogens, Pseudomonas aeruginosa and Staphylococcus aureus, by topical therapy with ciprofloxacin 0." | 7.75 | Differences in bacteriologic treatment failures in acute otitis externa between ciprofloxacin/dexamethasone and neomycin/polymyxin B/hydrocortisone: results of a combined analysis. ( Dohar, JE; McLean, C; Roland, P; Stroman, DW; Wall, GM, 2009) |
| "To evaluate the efficacy of a new nuclear imaging Infecton (Tc-99m ciprofloxacin) for the diagnosis of acute cholecystitis." | 7.74 | Tc-99m ciprofloxacin imaging in acute cholecystitis. ( Ahn, SI; Cho, YU; Choe, W; Choe, YM; Choi, SK; Hong, KC; Hur, YS; Kim, K; Kim, KR; Kim, SJ; Lee, KY; Shin, SH; Woo, ZH, 2007) |
| " We also investigated the efficacy and safety profile of once-daily ciprofloxacin in a 500-mg PO extended-release formulation for 3 days to treat acute cystitis." | 7.72 | A 'gap' between physician and patient assessment of symptom severity in acute cystitis?: a multicenter trial of women treated with extended-release ciprofloxacin. ( Brigio, FD; Colgan, R; Keating, KN; Perfetto, EM; Sirotenko, GA; Song, J; Tucker, MK; Wilson, K, 2004) |
| "The current results suggest that fluoroquinolone prophylaxis for patients with febrile neutropenia may be abandoned safely in areas with a high prevalence of ciprofloxacin-resistant enterobacteria." | 7.72 | Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli. ( Dalmau, D; Estany, C; Estrada, C; Garau, J; Gomez, L; Marquez, M; Martí, JM; Xercavins, M, 2003) |
| "Ciprofloxacin has been associated with several side effects including interstitial nephritis and hemolytic anemia." | 7.72 | Ciprofloxacin-induced acute interstitial nephritis and autoimmune hemolytic anemia. ( Alam, MG; Lim, S, 2003) |
| " The patient had initiated treatment with oral pantoprazole 40 mg/d for gastroesophageal reflux 2 months prior to admission." | 7.72 | Acute interstitial nephritis due to pantoprazole. ( Ra, A; Tobe, SW, 2004) |
| "With the aim to estimate the clinical and immunological efficiency of the ciprofloxacin (cifloxinal) 105 patients with acute (51), subacute (19) and chronic (35) brucellosis were studied." | 7.71 | [Ciprofloxacin in the treatment of patients with brucellosis]. ( Duĭsenova, AK; Kurmanova, GM; Kurmanova, KB, 2002) |
| "This study aimed to evaluate the efficacy and safety of oral antibacterial treatment with fluoroquinilone for acute uncomplicated pyelonephritis Thirteen female patients with acute uncomplicated pyelonephritis were treated with oral fluoroquinilone (ciprofloxacin; CPFX)." | 7.71 | Efficacy of a 14-day course of oral ciprofloxacin therapy for acute uncomplicated pyelonephritis. ( Hirose, T; Hisasue, SI; Itoh, N; Kato, R; Kunishima, Y; Matsukawa, M; Satoh, T; Shimizu, T; Takagi, S; Takahashi, S; Tsukamoto, T, 2001) |
| " In a murine model of hematogenous pyelonephritis, the in vivo efficacies of levofloxacin and ciprofloxacin were evaluated against two methicillin-susceptible and two methicillin-resistant S." | 7.69 | In vivo efficacies of levofloxacin and ciprofloxacin in acute murine hematogenous pyelonephritis induced by methicillin-susceptible and-resistant Staphylococcus aureus strains. ( Barrett, JF; Frosco, MB; Kulwich, BA; Licata, L; Melton, JL; Stewart, FP, 1996) |
| "To assess the clinical value of oral ciprofloxacin in the treatment of peritonitis in an intermittent peritoneal dialysis (IPD) population." | 7.68 | Poor response to oral ciprofloxacin in the treatment of peritonitis in patients on intermittent peritoneal dialysis. ( Fong, IW; Johnson, MD; Waite, NM; Webster, NR, 1993) |
| "Ciprofloxacin, a new quinolone derivative, was given prophylactically (500 mg twice a day) to 15 patients with acute leukemia during remission induction treatment for a mean duration of 42 days." | 7.67 | Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora. ( Dekker, AW; Rozenberg-Arska, M; Verhoef, J, 1985) |
| "025%, otic solution seems to be efficacious and safe in treating acute otitis externa (AOE) compared with ciprofloxacin, 0." | 7.11 | Efficacy and Safety of Ciprofloxacin Plus Fluocinolone Acetonide Among Patients With Acute Otitis Externa: A Randomized Clinical Trial. ( Aazami, H; Acosta, AM; Ansley, JF; Chu, L; De Valle, O; Dennis, P; Ehmer, D; Hedrick, JA, 2022) |
| "7%) of the patients receiving fluocinolone presented with adverse events related to study medication." | 6.84 | Efficacy and Safety of Ciprofloxacin Plus Fluocinolone in Otitis Media With Tympanostomy Tubes in Pediatric Patients: A Randomized Clinical Trial. ( Ansley, J; Butehorn, HF; Byers, J; Douglis, F; Esterhuizen, K; Hernández, FJ; Hussain, I; Ismail, K; Lanier, B; Lansford, B; Pumarola, F; Spektor, Z, 2017) |
| "Foam-based ciprofloxacin is a safe and an effective new treatment for AOE." | 6.75 | Comparison of safety and efficacy of foam-based versus solution-based ciprofloxacin for acute otitis externa. ( Eilat, E; Goldfarb, A; Marom, T; Rakover, Y; Roth, Y; Shlizerman, L; Yelin, R, 2010) |
| "Ciprofloxacin was shown to be noninferior to PNH." | 6.73 | Comparison of efficacy and safety of ciprofloxacin otic solution 0.2% versus polymyxin B-neomycin-hydrocortisone in the treatment of acute diffuse otitis externa*. ( Drehobl, M; Goldstein, G; Guerrero, JL; Lacarte, PR; Luber, S; Mata, FS, 2008) |
| "Ciprofloxacin treatment was successful in all nine patients with chlamydial or gonococcal PID and in six of seven with nonchlamydial nongonococcal PID." | 6.66 | A comparison of ciprofloxacin with doxycycline plus metronidazole in the treatment of acute pelvic inflammatory disease. ( Aine, R; Grönroos, P; Heinonen, PK; Miettinen, A; Punnonen, R; Teisala, K, 1989) |
| "Ciprofloxacin is an effective and safe treatment for uncomplicated urinary tract infection in general practice." | 6.66 | Ciprofloxacin versus amoxycillin/clavulanic acid in the treatment of urinary tract infections in general practice. ( Abbas, AM; Chandra, V; Dongaonkar, PP; Goel, PK; Kacker, P; Patel, NA; Shrivastava, OP; Thakkar, B; Tillotson, GS, 1989) |
| "Oral ciprofloxacin is a useful short-term treatment for patients with CF who are infected with Ps aeruginosa." | 6.66 | Oral ciprofloxacin compared with conventional intravenous treatment for Pseudomonas aeruginosa infection in adults with cystic fibrosis. ( Batten, JC; Butland, RJ; Hodson, ME; Roberts, CM; Smith, MJ, 1987) |
| "In a randomized study comparing cotrimoxazole plus colistin with ciprofloxacin, each in combination with nonabsorbable antimycotics, the incidence of major infections in terms of septicemias and pneumonias as well as of minor infections and episodes of unexplained fever (FUO) was higher in patients treated with ciprofloxacin." | 6.16 | Prevention of infection in acute leukemia. ( Daenen, S; de Pauw, BE; de Vries-Hospers, HG; Dekker, AW; Donnelly, JP; Gaus, W; Haralambie, E; Kern, W; Konrad, H; Maschmeyer, G, 1990) |
| "Ciprofloxacin was stopped and her pain quickly resolved." | 5.40 | Ciprofloxacin-induced tendinopathy of the gluteal tendons. ( Aronowitz, P; Shimatsu, K; Sim, H; Subramaniam, S, 2014) |
| "The study aimed to compare the efficacy and safety of Canephron N and ciprofloxacin as monotherapy in the management of mild forms of acute uncomplicated cystitis in women of working age." | 5.27 | [Comparative assessment of Canephron N and ciprofloxacin as monotherapy of acute uncomplicated cystitis in women]. ( Bunova, NE; Davidov, MI, 2018) |
| "Ciprofloxacin was tested in the acute and chronic experimental E." | 5.27 | [Ciprofloxacin and cefotaxim: pharmacokinetic and therapeutic effectiveness in E. coli pyelonephritis in rats]. ( Boness, J; Marre, R; Schulz, E; Tietgen, K, 1986) |
| "Adult women with acute cystitis symptoms and a ciprofloxacin-susceptible isolate in urine culture were included in a randomized, double-blind clinical trial." | 5.22 | A New Approach to the Treatment of Uncomplicated Cystitis: Results of a Randomized Placebo-Controlled Clinical Trial. ( Allegrini, A; García-Larrosa, A; Pavone, D; Salvatorelli, N, 2016) |
| "To determine whether cefpodoxime is noninferior to ciprofloxacin for treatment of acute cystitis." | 5.16 | Cefpodoxime vs ciprofloxacin for short-course treatment of acute uncomplicated cystitis: a randomized trial. ( Hooton, TM; Roberts, PL; Stapleton, AE, 2012) |
| "In a prospective, non-inferiority trial undertaken at 21 centres of infectious diseases in Sweden, women (aged ≥18 years) who were not pregnant and had a presumptive diagnosis of acute pyelonephritis were randomly assigned to oral treatment with ciprofloxacin 500 mg twice daily for 7 days or 14 days." | 5.16 | Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. ( Ekman, GS; Hermansson, AB; Kahlmeter, G; Kuylenstierna, N; Lannergård, A; Otto, G; Sandberg, T; Settergren, B; Skoog, G, 2012) |
| "This multicentre, double-blind study was undertaken to demonstrate non-inferiority of once-daily oral moxifloxacin compared with combination therapy in the management of acute, uncomplicated pelvic inflammatory disease (PID)." | 5.14 | A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease. ( Heystek, M; Ross, JD, 2009) |
| "Furagin (a nitrofurantoin analogue) has the same efficacy in treating acute cystitis as ciprofloxacin, however the duration of therapy is longer." | 5.13 | Ciprofloxacin and furagin in acute cystitis: comparison of early immune and microbiological results. ( Borkowski, A; Dybowski, B; Gromadzka-Ostrowska, J; Jabłońska, O; Radziszewski, P, 2008) |
| "A clinical study was conducted to compare the efficacy and safety of levofloxacin 750 mg once daily for 5 days to ciprofloxacin twice daily for 10 days for the treatment of complicated urinary tract infections (cUTI) or acute pyelonephritis (AP)." | 5.13 | A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis. ( Fisher, AC; Kahn, JB; Kaul, S; Khashab, M; Peterson, J, 2008) |
| "A double-blind, noninferiority trial was conducted to establish the safety and efficacy of a once-daily, 5-day course of levofloxacin 750 mg compared to a twice-daily, 10-day course of ciprofloxacin in complicated urinary tract infections (cUTI) and acute pyelonephritis (AP)." | 5.12 | A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis. ( Brown, P; Fisher, AC; Kahn, JB; Kaul, S; Khashab, M; Klausner, HA; Peterson, J, 2007) |
| "We assessed the efficacy and safety of 1,000 mg extended release ciprofloxacin orally once daily vs conventional 500 mg ciprofloxacin orally twice daily, each for 7 to 14 days, in patients with a complicated urinary tract infection (cUTI) or acute uncomplicated pyelonephritis (AUP)." | 5.11 | Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis. ( Church, DA; Klimberg, IW; Kowalsky, SF; Nicolle, LE; Song, J; Talan, DA, 2004) |
| "Pre-menopausal women presenting with acute uncomplicated cystitis were randomized to treatment with 3 days of ciprofloxacin, 7 days of nitrofurantoin, or a single dose of fosfomycin." | 5.11 | Isolation of fluoroquinolone-resistant rectal Escherichia coli after treatment of acute uncomplicated cystitis. ( Gupta, K; Hooton, TM; Stamm, WE, 2005) |
| "Randomized, patient-masked, parallel-group, multicenter trial of topical otic ciprofloxacin/dexamethasone versus topical ciprofloxacin alone in 201 children aged 6 months to 12 years with acute otitis media with tympanostomy tubes (AOMT) of less than or equal to 3 weeks' duration and visible otorrhea." | 5.10 | Topical ciprofloxacin/dexamethasone is superior to ciprofloxacin alone in pediatric patients with acute otitis media and otorrhea through tympanostomy tubes. ( Anon, JB; Conroy, PJ; Dupre, SJ; Hogg, G; Krueger, KA; Moe, RD; Potts, S; Roland, PS; Stroman, DW; Wall, GM, 2003) |
| "The study was undertaken to compare the safety and efficacy of twice-daily ciprofloxacin for 3 days with standard 7 day therapy with either co-trimoxazole or nitrofurantoin in the treatment of women with acute, uncomplicated urinary tract infections (UTI)." | 5.09 | A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection. ( Briefer, C; Echols, RM; Iravani, A; Klimberg, I; Kowalsky, SF; Munera, C, 1999) |
| "A multinational, multicentre, randomized, prospective, parallel-group study compared treatment with ciprofloxacin administered as an oral suspension (500 mg twice daily for 7 days) with co-amoxiclav tablets (625 mg three times daily for 7 days) in patients suffering from acute exacerbations of chronic bronchitis (AECB)." | 5.09 | The efficacy and safety of a new ciprofloxacin suspension compared with co-amoxiclav tablets in the treatment of acute exacerbations of chronic bronchitis. ( Berrisoul, F; Kearsley, N; Kubin, R; Kuss, A; Read, RC; Torres, A, 1999) |
| "Ciprofloxacin 500 mg orally twice daily was compared to pivampicillin 700 mg orally twice daily for 10 days in 172 men (41-85 years) with acute epididymitis." | 5.09 | [Ciprofloxacin and pivampicillin in acute epididymitis in men above the age of 40 years]. ( Eickhoff, JH; Frimodt-Møller, C; Frimodt-Møller, N; Walter, S, 2000) |
| "To evaluate the efficacy and safety of a suspension formulation of ciprofloxacin in the treatment of acute invasive diarrhea in infants and children." | 5.09 | Oral ciprofloxacin vs. intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children. ( Dagan, R; Janco, J; Leibovitz, E; Piglansky, L; Press, J; Reinhart, H; Yagupsky, P; Yaniv, I, 2000) |
| "To investigate the effects of an intravenous injection of tobramycin (T) in female patients with acute uncomplicated pyelonephritis treated with ciprofloxacin (CIP) (500 mg bid per os)." | 5.09 | [Acute pyelonephritis. Randomized multicenter double-blind study comparing ciprofloxacin with combined ciprofloxacin and tobramycin]. ( Baron, D; Bonnieux, J; Bourrier, P; Le Conte, P; Lebrin, P; Merit, JB; Potel, G; Simon, N, 2001) |
| "Metronidazole is effective for the treatment of acute pouchitis after ileal pouch-anal anastomosis, but it has not been directly compared with other antibiotics." | 5.09 | A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. ( Achkar, JP; Bambrick, ML; Bevins, CL; Brzezinski, A; Fazio, VW; Lashner, BA; Ormsby, AH; Remzi, FH; Seidner, DL; Shen, B, 2001) |
| "To compare the efficacy and safety of ciprofloxacin (CIP) oral suspension to trimethoprim/sulfamethoxazole (TMP/SMX) oral suspension among older women with acute urinary tract infections (UTIs)." | 5.09 | Efficacy and safety of ciprofloxacin oral suspension versus trimethoprim-sulfamethoxazole oral suspension for treatment of older women with acute urinary tract infection. ( Gomolin, IH; Haverstock, DC; Heyd, A; Reuning-Scherer, J; Siami, PF, 2001) |
| "One hundred consecutive patients with acute suppurative cholangitis were randomized in a prospective, controlled clinical trial to receive either ciprofloxacin (200 mg bd iv) or triple therapy comprising ceftazidime (1 g bd iv), ampicillin (500 mg qds iv) and metronidazole (500 mg tds iv); 46 and 44 patients in the ciprofloxacin and triple therapy groups respectively were suitable for inclusion in the analysis of efficacy." | 5.08 | Intravenous ciprofloxacin as treatment for patients with acute suppurative cholangitis: a randomized, controlled clinical trial. ( Cheng, AF; Chung, SC; Co, AL; Leung, JW; Li, AK; Lyon, DJ; Suen, R; Sung, JJ, 1995) |
| "We compare the bacteriological and clinical efficacy of rufloxacin and ciprofloxacin in patients with acute uncomplicated pyelonephritis." | 5.08 | Rufloxacin once daily versus ciprofloxacin twice daily in the treatment of patients with acute uncomplicated pyelonephritis. ( Bach, D; Cesana, M; Hübner, A; Plétan, Y; van Breukelen, G; van den Berg-Segers, A, 1995) |
| "A multicentric double-blind double-placebo randomized trial was conducted to compare the effectiveness and safety of ciprofloxacin versus pefloxacin given in a single oral dose in female out-patients with acute cystitis." | 5.08 | [Efficacy of single dose of ciprofloxacin and pefloxacin in the treatment of female acute cystitis]. ( Guibert, J, 1995) |
| "The aim of this study was to compare the efficacy of single-dose pefloxacin 400 mg and ciprofloxacin 250 mg in the treatment of acute uncomplicated gonococcal urethritis in males." | 5.08 | Comparing the efficacy of pefloxacin and ciprofloxacin in the treatment of acute uncomplicated gonococcal urethritis in males. ( Chan, RK; Cheong, LL; Goh, CL; Leow, YH; Nadarajah, M, 1995) |
| "/oral ciprofloxacin monotherapy offers a safe and efficacious alternative to standard parenteral therapy for acute pulmonary exacerbations in pediatric cystic fibrosis patients." | 5.08 | Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group. ( Church, DA; Echols, RM; Haverstock, DC; Kanga, JF; Kuhn, RJ; Painter, BG; Perroncel, RY; Rubio, TT; Spohn, WA; Stevens, JC; Thurberg, BE, 1997) |
| " This study examined the disposition of sequentially administered intravenous and oral ciprofloxacin, as well as provided dosing recommendations, for the treatment of acute pulmonary exacerbations in pediatric cystic fibrosis patients." | 5.08 | Pharmacokinetic disposition of sequential intravenous/oral ciprofloxacin in pediatric cystic fibrosis patients with acute pulmonary exacerbation. ( Church, DA; Echols, RM; Kuhn, RJ; Lettieri, JT; Miles, MV; Rubio, TT, 1997) |
| "A randomized, prospective, double-blind, double-dummy, multicenter study investigated the efficacy and safety of 10 days of oral therapy with grepafloxacin at 400 mg once daily, grepafloxacin at 600 mg once daily, or ciprofloxacin at 500 mg twice daily in 624 patients with acute bacterial exacerbations of chronic bronchitis." | 5.08 | Efficacy and safety of a 10-day course of 400 or 600 milligrams of grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: comparison with a 10-day course of 500 milligrams of ciprofloxacin twice daily. ( Breisch, S; Chodosh, S; Lakshminarayan, S; Swarz, H, 1998) |
| "We conducted a prospective, randomized, double-blind pilot study of oral ciprofloxacin (500 mg twice daily) versus cefuroxime axetil (250 mg twice daily) for 2 to 3 weeks in the treatment of adult patients with a clinical diagnosis of acute bacterial maxillary sinus infections or acute exacerbation of chronic bacterial sinusitis." | 5.08 | Ciprofloxacin versus cefuroxime axetil in the treatment of adult patients with acute bacterial sinusitis. ( Echols, RM; Heyd, A; Klein, GL; Whalen, E, 1998) |
| " The aim of this study was to investigate the efficacy of prophylactic intestinal decontamination with oral ciprofloxacin for the prevention of bacterial infections in cirrhotic patients with upper gastrointestinal bleeding." | 5.08 | The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding. ( Chang, FY; Hou, MC; Hsieh, WJ; Hwang, SJ; Lee, FY; Lee, SD; Lin, HC, 1998) |
| "To evaluate, in two randomized, multicenter trials, levofloxacin compared with ciprofloxacin and lomefloxacin for efficacy and safety in treating acute pyelonephritis." | 5.08 | Levofloxacin versus ciprofloxacin versus lomefloxacin in acute pyelonephritis. ( Callery-D'Amico, S; Fowler, CL; Kim, SS; Klimberg, IN; Richard, GA, 1998) |
| "In a prospective, multicenter, double-blind study, the interval to clinical relapse in patients with acute bacterial exacerbations of chronic bronchitis from whom a pretherapy pathogen was isolated was compared following treatment with ciprofloxacin or cefuroxime axetil." | 5.08 | Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group. ( Aneiro, L; Chodosh, S; Drehobl, M; Farkas, S; Kowalsky, S; McCarty, J; Shan, M; Tosiello, R, 1998) |
| "The role of ciprofloxacin and trimethoprim-sulfamethoxazole (TMP-SMZ) was evaluated in empiric treatment of uncomplicated Salmonella enteritis in a comparative, double-blind trial." | 5.07 | Ciprofloxacin and trimethoprim-sulfamethoxazole versus placebo in acute uncomplicated Salmonella enteritis: a double-blind trial. ( Bella, F; Cobo, E; Espejo, E; Freixas, N; Garau, J; García-Restoy, E; Lite, J; Sánchez, C; Sánchez, P; Simó, M, 1993) |
| "A total of 125 ambulatory women (85 premenopausal and 40 postmenopausal) who experienced 174 acute urinary tract infections with mainly gram-negative bacteria (99%) was randomized to receive a single dose, 2-tablet treatment with either ofloxacin (400 mg." | 5.07 | Single dose quinolone treatment in acute uncomplicated urinary tract infection in women. ( Pfau, A; Sacks, TG, 1993) |
| "A prospective, randomised trial was undertaken to compare the efficacy of ciprofloxacin and netilmicin for the treatment of acute pyelonephritis." | 5.07 | Comparison of ciprofloxacin with netilmicin for the treatment of acute pyelonephritis. ( Bailey, RR; Lynn, KL; Peddie, BA; Robson, RA; Smith, A, 1992) |
| "A prospective, randomized, controlled, non-blind clinical trial was conducted to compare the efficacy of monotherapy with ciprofloxacin with that of a combination of clindamycin plus gentamicin in the treatment of patients with acute pelvic inflammatory disease." | 5.06 | Efficacy of single-agent therapy for the treatment of acute pelvic inflammatory disease with ciprofloxacin. ( Crombleholme, WR; Luft, J; Ohm-Smith, M; Schachter, J; Sweet, RL; Whidden, R, 1989) |
| "In a double-blind, randomized, placebo-controlled trial 50 adult patients with acute diarrhea received either 500 mg ciprofloxacin b." | 5.06 | Ciprofloxacin in the treatment of acute bacterial diarrhea: a double blind study. ( Diridl, G; Pichler, H; Wolf, D, 1986) |
| "Oral ciprofloxacin was used at doses ranging from 500 mg to 1500 mg twice daily for 15 to 476 (mean 139) days for treatment of acute or chronic osteomyelitis in 38 patients, and acute arthritis in two." | 5.06 | Therapy of acute and chronic gram-negative osteomyelitis with ciprofloxacin. Report from a Swedish Study Group. ( , 1988) |
| "Fifty-six patients receiving remission induction treatment for acute leukemia were studied in a randomized trial comparing ciprofloxacin with trimethoprim-sulfamethoxazole plus colistin for prevention of infections." | 5.06 | Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin. ( Dekker, AW; Rozenberg-Arska, M; Verhoef, J, 1987) |
| "A 58-year-old male developed fulminating musculoskeletal pain associated with third-time exposure to ciprofloxacin administered for treatment of chronic otitis media." | 4.85 | Ciprofloxacin-related acute severe myalgia necessitating emergency care treatment: a case report and review of the literature. ( Eisele, S; Garbe, E; Schneider, T; Somasundaram, R; Zeitz, M, 2009) |
| "To evaluate the effects of prednisolone against sodium diclofenac both with ciprofloxacin compared to artificial tears on the symptoms and signs of acute viral conjunctivitis." | 3.96 | Comparative study on the efficacy of non-steroidal, steroid and non-use of anti-inflammatory in the treatment of acute epidemic conjunctivitis. ( Azevedo, OGR; Santiago, LA; Silva, JMRD; Vasconcelos, PRL, 2020) |
| "The objectives of this study were to investigate risk factors and the incidence of ciprofloxacin resistance and extended-spectrum beta-lactamases (ESBL) in patients with acute bacterial prostatitis (ABP)." | 3.83 | Risk Factor Analysis of Ciprofloxacin-Resistant and Extended Spectrum Beta-Lactamases Pathogen-Induced Acute Bacterial Prostatitis in Korea. ( Lee, DG; Lee, SH; Lee, Y; Yoo, KH, 2016) |
| "Ciprofloxacin is considered to be a safe and effective treatment for acute infectious colitis." | 3.80 | Acute pancreatitis secondary to ciprofloxacin therapy in patients with infectious colitis. ( Cheung, DY; Cho, HJ; Cho, SH; Kim, JI; Kim, JK; Kim, SS; Lee, HJ; Sung, HY, 2014) |
| "All patients with acute appendicitis at Sahlgrenska University Hospital (May 2009 and February 2010) were offered intravenous piperacillin plus tazobactam according to our previous experience, followed by 9 days out-hospital oral ciprofloxacin plus metronidazole." | 3.78 | Antibiotics as first-line therapy for acute appendicitis: evidence for a change in clinical practice. ( Hansson, J; Johnsson, E; Jönsson, C; Körner, U; Ludwigs, K; Lundholm, K, 2012) |
| " In this study, among the patients of brucellosis, whose diseases were recently diagnosed, 50 patients, receiving one of the two common authentic regimens of doxycycline plus rifampin for eight weeks or ciprofloxacin plus rifampin for six weeks, were selected." | 3.77 | A comparison between doxycycline-rifampin and ciprofloxacin-rifampin regimens in the treatment of acute Brucellosis. ( Hassani, M; Nozadi, MS; Taghvaee, MR, 2011) |
| "We investigated the risk factors for resistance to ciprofloxacin, cefazolin, ampicillin and co-trimoxazole in Escherichia coli isolates from urine of Korean female patients with acute uncomplicated cystitis (AUC)." | 3.76 | Risk factors for antimicrobial resistance among the Escherichia coli strains isolated from Korean patients with acute uncomplicated cystitis: a prospective and nationwide study. ( Cho, YH; Lee, G; Lee, SD; Shim, BS, 2010) |
| "To compare treatment failure rates for the two major acute otitis externa (AOE) pathogens, Pseudomonas aeruginosa and Staphylococcus aureus, by topical therapy with ciprofloxacin 0." | 3.75 | Differences in bacteriologic treatment failures in acute otitis externa between ciprofloxacin/dexamethasone and neomycin/polymyxin B/hydrocortisone: results of a combined analysis. ( Dohar, JE; McLean, C; Roland, P; Stroman, DW; Wall, GM, 2009) |
| "As typhoid fever was suspected and finally confirmed, the patient was treated with oral ciprofloxacin for 14 days." | 3.74 | [Acute myocarditis after visiting Pakistan]. ( Kohler, BM; Türoff, A; Vollnberg, H, 2008) |
| "To evaluate the efficacy of a new nuclear imaging Infecton (Tc-99m ciprofloxacin) for the diagnosis of acute cholecystitis." | 3.74 | Tc-99m ciprofloxacin imaging in acute cholecystitis. ( Ahn, SI; Cho, YU; Choe, W; Choe, YM; Choi, SK; Hong, KC; Hur, YS; Kim, K; Kim, KR; Kim, SJ; Lee, KY; Shin, SH; Woo, ZH, 2007) |
| " We also investigated the efficacy and safety profile of once-daily ciprofloxacin in a 500-mg PO extended-release formulation for 3 days to treat acute cystitis." | 3.72 | A 'gap' between physician and patient assessment of symptom severity in acute cystitis?: a multicenter trial of women treated with extended-release ciprofloxacin. ( Brigio, FD; Colgan, R; Keating, KN; Perfetto, EM; Sirotenko, GA; Song, J; Tucker, MK; Wilson, K, 2004) |
| "The current results suggest that fluoroquinolone prophylaxis for patients with febrile neutropenia may be abandoned safely in areas with a high prevalence of ciprofloxacin-resistant enterobacteria." | 3.72 | Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli. ( Dalmau, D; Estany, C; Estrada, C; Garau, J; Gomez, L; Marquez, M; Martí, JM; Xercavins, M, 2003) |
| "Ciprofloxacin has been associated with several side effects including interstitial nephritis and hemolytic anemia." | 3.72 | Ciprofloxacin-induced acute interstitial nephritis and autoimmune hemolytic anemia. ( Alam, MG; Lim, S, 2003) |
| "The aim of the present study was to characterize the population pharmacokinetics of ciprofloxacin in patients with and without cystic fibrosis ranging in age from 1 day to 24 years and to propose a limited sampling strategy to estimate individual pharmacokinetic parameters." | 3.72 | Population pharmacokinetics of ciprofloxacin in pediatric and adolescent patients with acute infections. ( Aigrain, Y; Aujard, Y; Bressolle, F; Jacqz-Aigrain, E; Munck, A; Payen, S; Serreau, R, 2003) |
| " The patient had initiated treatment with oral pantoprazole 40 mg/d for gastroesophageal reflux 2 months prior to admission." | 3.72 | Acute interstitial nephritis due to pantoprazole. ( Ra, A; Tobe, SW, 2004) |
| "In a previous study in experimental Klebsiella pneumoniae pneumonia, the therapeutic potential of ciprofloxacin was significantly improved by encapsulation in polyethylene glycol-coated ("pegylated") long-circulating (STEALTH) liposomes." | 3.71 | Ciprofloxacin in polyethylene glycol-coated liposomes: efficacy in rat models of acute or chronic Pseudomonas aeruginosa infection. ( Bakker-Woudenberg, IA; Guo, L; Mouton, JW; ten Kate, MT; Working, P, 2002) |
| "With the aim to estimate the clinical and immunological efficiency of the ciprofloxacin (cifloxinal) 105 patients with acute (51), subacute (19) and chronic (35) brucellosis were studied." | 3.71 | [Ciprofloxacin in the treatment of patients with brucellosis]. ( Duĭsenova, AK; Kurmanova, GM; Kurmanova, KB, 2002) |
| "This study aimed to evaluate the efficacy and safety of oral antibacterial treatment with fluoroquinilone for acute uncomplicated pyelonephritis Thirteen female patients with acute uncomplicated pyelonephritis were treated with oral fluoroquinilone (ciprofloxacin; CPFX)." | 3.71 | Efficacy of a 14-day course of oral ciprofloxacin therapy for acute uncomplicated pyelonephritis. ( Hirose, T; Hisasue, SI; Itoh, N; Kato, R; Kunishima, Y; Matsukawa, M; Satoh, T; Shimizu, T; Takagi, S; Takahashi, S; Tsukamoto, T, 2001) |
| " In a murine model of hematogenous pyelonephritis, the in vivo efficacies of levofloxacin and ciprofloxacin were evaluated against two methicillin-susceptible and two methicillin-resistant S." | 3.69 | In vivo efficacies of levofloxacin and ciprofloxacin in acute murine hematogenous pyelonephritis induced by methicillin-susceptible and-resistant Staphylococcus aureus strains. ( Barrett, JF; Frosco, MB; Kulwich, BA; Licata, L; Melton, JL; Stewart, FP, 1996) |
| " The intraocular pressure, which was 68 mmHg at the beginning was lowered with intravenous and per oral acetatcolamide together with timolol and pilocarpine eyedrops, and because of a narrow anterior chamber, with subsequent laser iridotomies." | 3.69 | Acute glaucoma and acute corneal oedema in association with tularemia. ( Pärssinen, O; Rummukainen, M, 1997) |
| "To assess the clinical value of oral ciprofloxacin in the treatment of peritonitis in an intermittent peritoneal dialysis (IPD) population." | 3.68 | Poor response to oral ciprofloxacin in the treatment of peritonitis in patients on intermittent peritoneal dialysis. ( Fong, IW; Johnson, MD; Waite, NM; Webster, NR, 1993) |
| "Ciprofloxacin, a new quinolone derivative, was given prophylactically (500 mg twice a day) to 15 patients with acute leukemia during remission induction treatment for a mean duration of 42 days." | 3.67 | Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora. ( Dekker, AW; Rozenberg-Arska, M; Verhoef, J, 1985) |
| "025%, otic solution seems to be efficacious and safe in treating acute otitis externa (AOE) compared with ciprofloxacin, 0." | 3.11 | Efficacy and Safety of Ciprofloxacin Plus Fluocinolone Acetonide Among Patients With Acute Otitis Externa: A Randomized Clinical Trial. ( Aazami, H; Acosta, AM; Ansley, JF; Chu, L; De Valle, O; Dennis, P; Ehmer, D; Hedrick, JA, 2022) |
| "Bacterial infections are common during induction therapy in children and adolescents with acute leukaemia and may cause infection-related mortality." | 3.01 | Comparative effectiveness and safety of antibiotic prophylaxis during induction chemotherapy in children with acute leukaemia: a systematic review and meta-analysis. ( Cheng, G; Diao, S; Jia, Z; Lu, X; Luo, J; Xin, L; Yang, M; Zeng, L; Zhang, L, 2023) |
| "7%) of the patients receiving fluocinolone presented with adverse events related to study medication." | 2.84 | Efficacy and Safety of Ciprofloxacin Plus Fluocinolone in Otitis Media With Tympanostomy Tubes in Pediatric Patients: A Randomized Clinical Trial. ( Ansley, J; Butehorn, HF; Byers, J; Douglis, F; Esterhuizen, K; Hernández, FJ; Hussain, I; Ismail, K; Lanier, B; Lansford, B; Pumarola, F; Spektor, Z, 2017) |
| "Of these 22, only 1 patient (5%) had recurrence of acute appendicitis during follow-up." | 2.80 | Nonoperative treatment with antibiotics versus surgery for acute nonperforated appendicitis in children: a pilot randomized controlled trial. ( Almström, M; Eaton, S; Hall, NJ; Naji, H; Patkova, B; Pierro, A; Svensson, JF; Wester, T, 2015) |
| "Upper respiratory tract infections (URTI) frequently cause exacerbations of chronic-obstructive pulmonary disease (COPD)." | 2.76 | Echinacea purpurea along with zinc, selenium and vitamin C to alleviate exacerbations of chronic obstructive pulmonary disease: results from a randomized controlled trial. ( Isbaniah, F; Setiawati, A; Totzke, U; Verbruggen, MA; Wiyono, WH; Yunus, F, 2011) |
| "Foam-based ciprofloxacin is a safe and an effective new treatment for AOE." | 2.75 | Comparison of safety and efficacy of foam-based versus solution-based ciprofloxacin for acute otitis externa. ( Eilat, E; Goldfarb, A; Marom, T; Rakover, Y; Roth, Y; Shlizerman, L; Yelin, R, 2010) |
| "In most of the patients studied, ambulatory conservative management was safe and effective in the treatment of uncomplicated acute diverticulitis." | 2.74 | [Safety and efficiency of ambulatory treatment of acute diverticulitis]. ( García Marín, A; Martín Gil, J; Pérez Díaz, MD; Rey Valcárcel, C; Sanz Sánchez, M; Serralta De Colsa, D; Turégano Fuentes, F; Vaquero Rodríguez, A, 2009) |
| "Ciprofloxacin was shown to be noninferior to PNH." | 2.73 | Comparison of efficacy and safety of ciprofloxacin otic solution 0.2% versus polymyxin B-neomycin-hydrocortisone in the treatment of acute diffuse otitis externa*. ( Drehobl, M; Goldstein, G; Guerrero, JL; Lacarte, PR; Luber, S; Mata, FS, 2008) |
| "The value of antibiotics in the treatment of reactive arthritis (ReA) is still controversial." | 2.71 | Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis. ( Hakola, M; Korpela, M; Luukkainen, R; Möttönen, T; Sanila, M; Toivanen, A; Uksila, J; Yli-Kerttula, T; Yli-Kerttula, U, 2003) |
| "Ciprofloxacin/dexamethasone treatment is also superior to improvement in clinical response by visit, absence of otorrhea by visit, and reduction of otorrhea volume by visit." | 2.71 | Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes. ( Anon, JB; Conroy, PJ; Dupre, SJ; Hogg, G; Kreisler, LS; Lanier, B; McLean, C; Potts, S; Reese, B; Roland, PS; Stroman, DW; Wall, GM, 2004) |
| "To evaluate QOL in women treated for acute cystitis, and describe the relationship between QOL, clinical outcome and adverse events of each of the interventions used in the study." | 2.71 | Women's quality of life is decreased by acute cystitis and antibiotic adverse effects associated with treatment. ( Bergus, GR; Ernst, EJ; Ernst, ME; Hoehns, JD, 2005) |
| "The role of antibiotics in the treatment of ulcerative colitis is controversial." | 2.70 | A prospective randomized controlled trial of intravenous ciprofloxacin as an adjunct to corticosteroids in acute, severe ulcerative colitis. ( Amberiadis, P; Archavlis, E; Christidou, A; Kourtessas, D; Mantzaris, GJ; Petraki, K; Triantafyllou, G, 2001) |
| "Three studies were undertaken to determine the minimum effective dosing regimen of ciprofloxacin for the treatment of acute, symptomatic, uncomplicated lower urinary tract infection." | 2.68 | Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected]. ( Gallis, HA; Heyd, A; Iravani, A; Kowalsky, SF; McCarty, J; Nolen, T; Sikes, DH; Tice, AD; Tosiello, RL; Whalen, EP, 1995) |
| "Ciprofloxacin was well tolerated." | 2.67 | Value of single-dose ciprofloxacin in the treatment of acute uncomplicated urinary tract infection in women. ( Adracta, DJ; Georgiopoulos, AN; Karachalios, GN; Nasopoulou-Papadimitriou, DD, 1991) |
| "Despite its excellent antimicrobial activity against salmonellae and its favorable pharmacokinetic profile, ciprofloxacin at a dosage of 750 mg orally twice daily had an unacceptably high failure rate in patients with acute salmonellosis and may have prolonged fecal excretion of salmonellae." | 2.67 | Failure of ciprofloxacin to eradicate convalescent fecal excretion after acute salmonellosis: experience during an outbreak in health care workers. ( Cassidy, JE; Giusti, R; Heelan, J; Mayer, KH; Neill, MA; Opal, SM; White, R, 1991) |
| "Ciprofloxacin treatment was successful in all nine patients with chlamydial or gonococcal PID and in six of seven with nonchlamydial nongonococcal PID." | 2.66 | A comparison of ciprofloxacin with doxycycline plus metronidazole in the treatment of acute pelvic inflammatory disease. ( Aine, R; Grönroos, P; Heinonen, PK; Miettinen, A; Punnonen, R; Teisala, K, 1989) |
| "Ciprofloxacin is an effective and safe treatment for uncomplicated urinary tract infection in general practice." | 2.66 | Ciprofloxacin versus amoxycillin/clavulanic acid in the treatment of urinary tract infections in general practice. ( Abbas, AM; Chandra, V; Dongaonkar, PP; Goel, PK; Kacker, P; Patel, NA; Shrivastava, OP; Thakkar, B; Tillotson, GS, 1989) |
| "Oral ciprofloxacin is a useful short-term treatment for patients with CF who are infected with Ps aeruginosa." | 2.66 | Oral ciprofloxacin compared with conventional intravenous treatment for Pseudomonas aeruginosa infection in adults with cystic fibrosis. ( Batten, JC; Butland, RJ; Hodson, ME; Roberts, CM; Smith, MJ, 1987) |
| "Pouchitis is a common and long-term complication of ileal pouch-anal anastomosis in patients with underlying ulcerative colitis." | 2.43 | [Diagnosis and medical treatment of pouchitis in ileal pouch-anal anastomosis in patients with ulcerative colitis]. ( Fujii, T; Kawamata, S; Matsushita, M; Okazaki, K; Shimatani, M, 2005) |
| "Uncomplicated acute cystitis is one of the most common bacterial infections in adults." | 2.43 | Quinolones for uncomplicated acute cystitis in women. ( Andreeva, I; Rafalsky, V; Rjabkova, E, 2006) |
| "Patients who are treated for acute leukemia should be offered prophylaxis with ciprofloxacin or levofloxacin." | 2.43 | Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions. ( Bucaneve, G; Cullen, M; Fraser, A; Gafter-Gvili, A; Kern, WV; Leibovici, L; Paul, M, 2006) |
| "Factors predictive of recurrence are, according to another study, dependence on oxygen therapy, prolonged corticosteroid therapy, smoking, and/or heart disease." | 2.41 | [Objectives for antibiotic therapy in acute exacerbations of chronic bronchitis]. ( Gaillat, J, 2001) |
| "The elective treatment for acute pouchitis is antibiotics." | 1.56 | Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 2: Treatment. ( Barreiro-de Acosta, M; Beltrán, B; Chaparro, M; Espín, E; Ferrer Bradley, I; Gisbert, JP; Guarner, F; Gutiérrez, A; Marín-Jimenez, I; Nos, P; Rodríguez-Lago, I, 2020) |
| " While the use of topical drops can minimize the administered dose of antibiotic and adverse systemic effects compared to oral antibiotics, their use has limitations, partially due to low patient compliance, high dosing frequency, and difficulty of administration." | 1.56 | Controlled release of ciprofloxacin and ceftriaxone from a single ototopical administration of antibiotic-loaded polymer microspheres and thermoresponsive gel. ( Alper, CM; Bruk, LA; Dunkelberger, KE; Fedorchak, MV; Hong, W; Khampang, P; Sadagopan, S, 2020) |
| "Campylobacter infections are typically self-limited, but in cases with severe enteritis, immuno-compromised system and bacteremia, an appropriate antimicrobial treatment is demanding." | 1.51 | Antimicrobial Susceptibility of Campylobacter isolates in the Capital of North Macedonia. ( Blazevska, A; Kostovski, M; Mihajlov, K; Mirchevska, G; Stojkovska, S; Trajkovska-Dokic, E, 2019) |
| "Thyroiditis was diagnosed with clinical inspection and confirmed by ultrasound investigation." | 1.51 | Acute Thyroiditis Associated with Brucellosis: A Case Report. ( Bitoska, I; Bosilkovski, M; Cvetkova, M; Jakimovski, D; Poposki, K, 2019) |
| "Treatment with voriconazole was promptly started with success." | 1.43 | Acute isolated appendicitis due to Aspergillus carneus in a neutropenic child with acute myeloid leukemia. ( Bergami, E; Cavanna, C; Decembrino, N; Introzzi, F; Lallitto, F; Mangione, F; Marone, P; Tamarozzi, F; Tortorano, AM; Zecca, M, 2016) |
| "Proper use of antibiotics in the treatment of acute diarrhea is crucial due to the high level of antibiotic resistance." | 1.43 | Viral and Bacterial Etiology of Acute Diarrhea among Children under 5 Years of Age in Wuhan, China. ( Cheng, ZJ; Li, S; Liu, WY; Sun, ZY; Tian, L; Xiang, X; Yu, WT; Zhang, WQ; Zhu, XH, 2016) |
| "P." | 1.42 | Bloodstream bacterial infection among outpatient children with acute febrile illness in north-eastern Tanzania. ( Butichi, A; Lemnge, M; Lushino, P; Lusingu, J; Mahende, C; Mmbando, B; Ngasala, B; Premji, Z, 2015) |
| " Lead optimization resulted in the identification of potent compounds with improved oral bioavailability and reduced cardiac ion channel liability." | 1.40 | Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis. ( Achar, V; Arora, U; Awasthy, D; Bharath, S; Bheemarao, U; Chinnapattu, M; Coulson, M; de Sousa, SM; Ganguly, S; Gaonkar, S; Ghosh, A; Hameed P, S; Hoffner, S; Humnabadkar, V; Kaur, P; Kumar K N, M; Kumar, CN; Madhavapeddi, P; Manjrekar, P; Menasinakai, S; Mukherjee, K; Nandishaiah, R; Narayan, C; Panduga, V; Patil, V; Puttur, J; Raichurkar, A; Ramya, VK; Reddy, J; Rudrapatana, S; Sambandamurthy, VK; Shanbhag, G; Sharma, S; Sharma, U; Shinde, V; Solapure, S; Waterson, D; Werngren, J, 2014) |
| "Ciprofloxacin was stopped and her pain quickly resolved." | 1.40 | Ciprofloxacin-induced tendinopathy of the gluteal tendons. ( Aronowitz, P; Shimatsu, K; Sim, H; Subramaniam, S, 2014) |
| "Oculoglandular tularemia is not only suspected in cases who complain of fever, cervical lymphadenopathy and purulent conjunctivitis, it should also be suspected in cases who are admitted to the hospital with acute dacryocystitis, which is a rare component of oculoglandular syndrome." | 1.39 | Unilateral acute dacryocystitis associated with oculoglandular tularemia: a case report. ( Celik, T; Kosker, M; Turkoglu, EB; Yuksel, D, 2013) |
| "This study evaluated the incidence and treatment of pouchitis in Japanese ulcerative colitis patients." | 1.39 | Clinical features and management of pouchitis in Japanese ulcerative colitis patients. ( Bando, T; Ikeuchi, H; Matsuoka, H; Takesue, Y; Tomita, N; Uchino, M, 2013) |
| "Human African trypanosomiasis (HAT) or sleeping sickness is caused by two subspecies of Trypanosoma brucei , Trypanosoma brucei gambiense , and Trypanosoma brucei rhodesiense and is one of Africa's old plagues." | 1.38 | Synthesis and structure-activity relationships of new quinolone-type molecules against Trypanosoma brucei. ( Braunschweig, H; Damme, A; Engstler, M; Hiltensperger, G; Holzgrabe, U; Jones, NG; Jung, J; Kaiser, M; Meinel, L; Niedermeier, S; Puhl, S; Stich, A, 2012) |
| "Ciprofloxacin was given to 97% patients along with fluid administration, and 78% were found to be resistant to quinolones." | 1.38 | Clinical characteristics and predictors of positive stool culture in adult patients with acute gastroenteritis. ( Anwar, MA; Awan, S; Hilal, H; Khan, MS; Patel, MJ; Razi, S; Riaz, MM; Tariq, M, 2012) |
| "Ciprofloxacin was prescribed for 37 (2." | 1.37 | Antibiotic prescribing for adults with acute cough/lower respiratory tract infection: congruence with guidelines. ( Blasi, F; Butler, CC; Coenen, S; Goossens, H; Hood, K; Kelly, MJ; Little, P; Nuttall, J; Schaberg, T; Torres, A; Verheij, T; Wood, J, 2011) |
| "Acute phlegmonous gastritis is an uncommon disease, often fatal condition characterized by suppurative bacterial infection of the gastric wall." | 1.37 | [A case of acute phlegmonous gastritis causing gastroparesis and cured with medical treatment alone]. ( Kim, JS; Kim, NY; Lee, KJ; Park, JS; Yun, HK, 2011) |
| "Nevertheless, Serratia infections are especially frequent in chronic granulomatous disease, which is a primary immunodeficiency that affects phagocytic cells of the innate immune system." | 1.35 | Acute dermal abscesses caused by Serratia marcescens. ( Bielsa, I; Carrascosa, JM; Domingo, H; Ferrándiz, C; Herrero, MJ; Ribera, M; Soria, X, 2008) |
| "Here, we present a case of Escherichia coli meningitis after TBP despite quinolone prophylaxis." | 1.35 | Acute bacterial meningitis after transrectal needle biopsy of the prostate: a case report. ( Arslan, H; Ekinci, MN; Erdogan, A; Erdogan, H; Hoscan, MB, 2008) |
| "Escherichia coli meningitis is a frequent pathology in children younger than 3 years old, but is an uncommon disease in adults." | 1.33 | E. coli multiresistant meningitis after transrectal prostate biopsy. ( Alecsandru, D; Garcia, A; Gestoso, I; Lobo, J; Martinez, A; Romero, A; Yagüe, MR, 2006) |
| "Ciprofloxacin can induce interstitial pneumonitis with acute respiratory failure." | 1.32 | Ciprofloxacin-induced acute interstitial pneumonitis. ( Bubendorf, L; Leuppi, JD; Oberholzer, M; Steiger, D; Tamm, M, 2004) |
| "Nalidixic acid resistance was observed in 6/13 (46." | 1.32 | Emergence of nalidixic acid resistance in Shigella sonnei isolated from patients having acute diarrheal disease: report from eastern province of Saudi Arabia. ( Al-Mulhim, K; Panhotra, BR; Saxena, AK, 2004) |
| "We report a case of agranulocytosis which developed 3 weeks after onset of acute hepatitis B in an HIV-positive patient." | 1.31 | [Agranulocytosis in acute hepatitis B in an HIV seropositive patient]. ( Brazille, P; Coutant-Perronne, V; Malkin, JE; Raguin, G, 2000) |
| " Dosing regimens were chosen to obtain a comparable area under the concentration-time curve from 0 to infinity/MIC ratio of 27." | 1.31 | Differential selection of multidrug efflux mutants by trovafloxacin and ciprofloxacin in an experimental model of Pseudomonas aeruginosa acute pneumonia in rats. ( Carbon, C; Chau, F; Dautrey, S; Faurisson, F; Join-Lambert, OF; Köhler, T; Michéa-Hamzehpour, M; Pechère, J; Vissuzaine, C, 2001) |
| "After diagnostic work-up, we diagnosed Yersinia enterocolitica infection." | 1.31 | Case report: an unusual presentation of Yersinia enterocolitica infection. ( Begashaw, K; Jaspers, CA, 2001) |
| "The authors report two cases of transverse myelitis due to Mycoplasma pneumoniae occurring during a recent acute infection due to Epstein-Barr virus (EBV)." | 1.31 | Transverse myelitis associated with Mycoplasma pneumoniae pneumonitis: a report of two cases. ( Filice, G; Parisi, A, 2001) |
| "Ciprofloxacin use can cause an acute reversible arthropathy, but in this study there is no evidence that its use can cause a delayed arthropathy or any permanent joint damage." | 1.29 | Ciprofloxacin use: acute arthropathy and long-term follow up. ( Karande, S; Kshirsagar, NA, 1996) |
| "Ciprofloxacin was tested in the acute and chronic experimental E." | 1.27 | [Ciprofloxacin and cefotaxim: pharmacokinetic and therapeutic effectiveness in E. coli pyelonephritis in rats]. ( Boness, J; Marre, R; Schulz, E; Tietgen, K, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (9.09) | 18.7374 |
| 1990's | 71 (29.34) | 18.2507 |
| 2000's | 83 (34.30) | 29.6817 |
| 2010's | 55 (22.73) | 24.3611 |
| 2020's | 11 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Griffith, ME | 1 |
| Moon, JE | 1 |
| Johnson, EN | 1 |
| Clark, KP | 1 |
| Hawley, JS | 1 |
| Hospenthal, DR | 1 |
| Murray, CK | 1 |
| Hiltensperger, G | 1 |
| Jones, NG | 1 |
| Niedermeier, S | 1 |
| Stich, A | 1 |
| Kaiser, M | 1 |
| Jung, J | 1 |
| Puhl, S | 1 |
| Damme, A | 1 |
| Braunschweig, H | 1 |
| Meinel, L | 1 |
| Engstler, M | 1 |
| Holzgrabe, U | 1 |
| Hameed P, S | 1 |
| Patil, V | 1 |
| Solapure, S | 1 |
| Sharma, U | 1 |
| Madhavapeddi, P | 1 |
| Raichurkar, A | 1 |
| Chinnapattu, M | 1 |
| Manjrekar, P | 1 |
| Shanbhag, G | 1 |
| Puttur, J | 1 |
| Shinde, V | 1 |
| Menasinakai, S | 1 |
| Rudrapatana, S | 1 |
| Achar, V | 1 |
| Awasthy, D | 1 |
| Nandishaiah, R | 1 |
| Humnabadkar, V | 1 |
| Ghosh, A | 1 |
| Narayan, C | 1 |
| Ramya, VK | 1 |
| Kaur, P | 1 |
| Sharma, S | 1 |
| Werngren, J | 1 |
| Hoffner, S | 1 |
| Panduga, V | 1 |
| Kumar, CN | 1 |
| Reddy, J | 1 |
| Kumar K N, M | 1 |
| Ganguly, S | 1 |
| Bharath, S | 1 |
| Bheemarao, U | 1 |
| Mukherjee, K | 1 |
| Arora, U | 1 |
| Gaonkar, S | 1 |
| Coulson, M | 1 |
| Waterson, D | 1 |
| Sambandamurthy, VK | 1 |
| de Sousa, SM | 1 |
| Chu, L | 1 |
| Acosta, AM | 1 |
| Aazami, H | 1 |
| Dennis, P | 1 |
| De Valle, O | 1 |
| Ehmer, D | 1 |
| Hedrick, JA | 1 |
| Ansley, JF | 1 |
| Hope, PKF | 1 |
| Lynen, L | 1 |
| Mensah, B | 1 |
| Appiah, F | 1 |
| Kamau, EM | 1 |
| Ashubwe-Jalemba, J | 1 |
| Peprah Boaitey, K | 1 |
| Adomako, LAB | 1 |
| Alaverdyan, S | 1 |
| Appiah-Thompson, BL | 1 |
| Kwarteng Amaning, E | 1 |
| Baanam, MY | 1 |
| Yang, M | 1 |
| Lu, X | 1 |
| Xin, L | 1 |
| Luo, J | 1 |
| Diao, S | 1 |
| Jia, Z | 1 |
| Cheng, G | 1 |
| Zeng, L | 1 |
| Zhang, L | 1 |
| Jansson-Knodell, CL | 1 |
| Shin, A | 1 |
| Rogers, N | 1 |
| Çağatay, AA | 1 |
| Deniz, R | 1 |
| Gözüküçük, R | 1 |
| Özbek, E | 1 |
| Başaran, S | 1 |
| Trajkovska-Dokic, E | 1 |
| Mihajlov, K | 1 |
| Mirchevska, G | 1 |
| Kostovski, M | 1 |
| Blazevska, A | 1 |
| Stojkovska, S | 1 |
| Cvetkova, M | 1 |
| Bitoska, I | 1 |
| Poposki, K | 1 |
| Jakimovski, D | 1 |
| Bosilkovski, M | 1 |
| Guo, RF | 1 |
| Nguyen, DL | 1 |
| Park, S | 1 |
| Nguyen, K | 1 |
| Ko, S | 1 |
| Chiu, VY | 1 |
| Dickter, J | 1 |
| Becker, D | 1 |
| Cho, P | 1 |
| Santiago, LA | 1 |
| Silva, JMRD | 1 |
| Azevedo, OGR | 1 |
| Vasconcelos, PRL | 1 |
| Beaussac, M | 1 |
| Luciano, L | 1 |
| Savini, H | 1 |
| Deniel, C | 1 |
| Javelle, E | 1 |
| Coton, T | 1 |
| Simon, F | 1 |
| Barreiro-de Acosta, M | 1 |
| Marín-Jimenez, I | 1 |
| Rodríguez-Lago, I | 1 |
| Guarner, F | 1 |
| Espín, E | 1 |
| Ferrer Bradley, I | 1 |
| Gutiérrez, A | 1 |
| Beltrán, B | 1 |
| Chaparro, M | 1 |
| Gisbert, JP | 1 |
| Nos, P | 1 |
| Neguse, S | 1 |
| Bruk, LA | 1 |
| Dunkelberger, KE | 1 |
| Khampang, P | 1 |
| Hong, W | 1 |
| Sadagopan, S | 1 |
| Alper, CM | 1 |
| Fedorchak, MV | 1 |
| Orhan Kubat, G | 1 |
| Dogan, B | 1 |
| Sellami, M | 1 |
| Mnejja, M | 1 |
| Masmoudi, M | 1 |
| Maalej, F | 1 |
| Charfeddine, I | 1 |
| Ghorbel, A | 1 |
| Cazals-Hatem, D | 1 |
| Bosch-Nicolau, P | 1 |
| Falcó, V | 1 |
| Viñado, B | 1 |
| Andreu, A | 1 |
| Len, O | 1 |
| Almirante, B | 1 |
| Pigrau, C | 1 |
| Cattrall, JWS | 1 |
| Robinson, AV | 1 |
| Kirby, A | 1 |
| Fadel, MG | 1 |
| Louis, C | 1 |
| Tay, A | 1 |
| Bolgeri, M | 1 |
| Davidov, MI | 1 |
| Bunova, NE | 1 |
| Celik, T | 1 |
| Yuksel, D | 1 |
| Kosker, M | 1 |
| Turkoglu, EB | 1 |
| Taghvaee, MR | 1 |
| Nozadi, MS | 1 |
| Hassani, M | 1 |
| Fatima, A | 1 |
| Afridi, FI | 1 |
| Qureshi, A | 1 |
| Farooqi, BJ | 1 |
| Hussain, A | 1 |
| Sun, Z | 1 |
| Shi, J | 1 |
| Liu, C | 1 |
| Jin, Y | 1 |
| Li, K | 1 |
| Chen, R | 1 |
| Jin, S | 1 |
| Wu, W | 1 |
| Park, KH | 1 |
| Oh, WS | 1 |
| Kim, ES | 1 |
| Park, SW | 1 |
| Hur, JA | 1 |
| Kim, YK | 1 |
| Moon, C | 1 |
| Lee, JH | 1 |
| Lee, CS | 1 |
| Kim, BN | 1 |
| Sung, HY | 1 |
| Kim, JI | 1 |
| Lee, HJ | 1 |
| Cho, HJ | 1 |
| Cheung, DY | 1 |
| Kim, SS | 2 |
| Cho, SH | 1 |
| Kim, JK | 1 |
| Shimatsu, K | 1 |
| Subramaniam, S | 1 |
| Sim, H | 1 |
| Aronowitz, P | 1 |
| Svensson, JF | 1 |
| Patkova, B | 1 |
| Almström, M | 1 |
| Naji, H | 1 |
| Hall, NJ | 1 |
| Eaton, S | 1 |
| Pierro, A | 1 |
| Wester, T | 1 |
| Ercibengoa Arana, M | 1 |
| Marimón Ortiz de Zarate, JM | 1 |
| Mahende, C | 1 |
| Ngasala, B | 1 |
| Lusingu, J | 1 |
| Butichi, A | 1 |
| Lushino, P | 1 |
| Lemnge, M | 1 |
| Mmbando, B | 1 |
| Premji, Z | 1 |
| Pasiechnikov, S | 1 |
| Buchok, O | 1 |
| Sheremeta, R | 1 |
| Banyra, O | 1 |
| Lübbert, C | 1 |
| Kim, HY | 1 |
| Lee, SJ | 1 |
| Lee, DS | 1 |
| Yoo, JM | 1 |
| Choe, HS | 1 |
| Diamandis, EP | 1 |
| Decembrino, N | 1 |
| Zecca, M | 1 |
| Tortorano, AM | 1 |
| Mangione, F | 1 |
| Lallitto, F | 1 |
| Introzzi, F | 1 |
| Bergami, E | 1 |
| Marone, P | 1 |
| Tamarozzi, F | 1 |
| Cavanna, C | 1 |
| Salvatorelli, N | 1 |
| García-Larrosa, A | 1 |
| Allegrini, A | 1 |
| Pavone, D | 1 |
| Moya, P | 2 |
| Bellon, M | 1 |
| Arroyo, A | 2 |
| Galindo, I | 1 |
| Candela, F | 2 |
| Lacueva, J | 1 |
| Calpena, R | 2 |
| Zhu, XH | 1 |
| Tian, L | 1 |
| Cheng, ZJ | 1 |
| Liu, WY | 1 |
| Li, S | 1 |
| Yu, WT | 1 |
| Zhang, WQ | 1 |
| Xiang, X | 1 |
| Sun, ZY | 1 |
| Lee, Y | 1 |
| Lee, DG | 1 |
| Lee, SH | 1 |
| Yoo, KH | 1 |
| Spektor, Z | 1 |
| Pumarola, F | 1 |
| Ismail, K | 1 |
| Lanier, B | 2 |
| Hussain, I | 1 |
| Ansley, J | 1 |
| Butehorn, HF | 1 |
| Esterhuizen, K | 1 |
| Byers, J | 1 |
| Douglis, F | 1 |
| Lansford, B | 1 |
| Hernández, FJ | 1 |
| Steurer, J | 1 |
| Türoff, A | 1 |
| Vollnberg, H | 1 |
| Kohler, BM | 1 |
| Beck, N | 1 |
| Folia, M | 1 |
| Mahy, S | 1 |
| Duvillard, C | 1 |
| Chanteret, C | 1 |
| Lecomte, H | 1 |
| Gazzano, E | 1 |
| Piroth, L | 1 |
| Romanet, P | 1 |
| Drehobl, M | 2 |
| Guerrero, JL | 1 |
| Lacarte, PR | 1 |
| Goldstein, G | 1 |
| Mata, FS | 1 |
| Luber, S | 1 |
| Grocholski, AS | 1 |
| Delage, M | 1 |
| Samimi, M | 1 |
| Maruani, A | 1 |
| Dohar, JE | 1 |
| Roland, P | 2 |
| Wall, GM | 3 |
| McLean, C | 3 |
| Stroman, DW | 3 |
| Martín Gil, J | 1 |
| Serralta De Colsa, D | 1 |
| García Marín, A | 1 |
| Vaquero Rodríguez, A | 1 |
| Rey Valcárcel, C | 1 |
| Pérez Díaz, MD | 1 |
| Sanz Sánchez, M | 1 |
| Turégano Fuentes, F | 1 |
| Eisele, S | 1 |
| Garbe, E | 1 |
| Zeitz, M | 1 |
| Schneider, T | 1 |
| Somasundaram, R | 1 |
| Pezzilli, R | 1 |
| Kavanagh, KR | 1 |
| Parham, K | 1 |
| Schoem, SR | 1 |
| Tucker, MK | 1 |
| Brigio, FD | 1 |
| Sirotenko, GA | 1 |
| Keating, KN | 1 |
| Perfetto, EM | 1 |
| Wilson, K | 1 |
| Song, J | 3 |
| Colgan, R | 2 |
| Heystek, M | 1 |
| Ross, JD | 1 |
| Alonso, S | 1 |
| Pera, M | 2 |
| Parés, D | 2 |
| Pascual, M | 1 |
| Gil, MJ | 2 |
| Courtier, R | 2 |
| Grande, L | 1 |
| Nicoletti, J | 1 |
| Kuster, SP | 1 |
| Sulser, T | 1 |
| Zbinden, R | 1 |
| Ruef, C | 1 |
| Ledergerber, B | 1 |
| Weber, R | 1 |
| Lee, G | 1 |
| Cho, YH | 1 |
| Shim, BS | 1 |
| Lee, SD | 2 |
| Marom, T | 1 |
| Yelin, R | 1 |
| Goldfarb, A | 1 |
| Rakover, Y | 1 |
| Shlizerman, L | 1 |
| Eilat, E | 1 |
| Roth, Y | 1 |
| Isbaniah, F | 1 |
| Wiyono, WH | 1 |
| Yunus, F | 1 |
| Setiawati, A | 1 |
| Totzke, U | 1 |
| Verbruggen, MA | 1 |
| Wood, J | 1 |
| Butler, CC | 1 |
| Hood, K | 1 |
| Kelly, MJ | 1 |
| Verheij, T | 1 |
| Little, P | 1 |
| Torres, A | 2 |
| Blasi, F | 1 |
| Schaberg, T | 1 |
| Goossens, H | 1 |
| Nuttall, J | 1 |
| Coenen, S | 1 |
| Growcott, EJ | 1 |
| Coulthard, A | 1 |
| Amison, R | 1 |
| Hardaker, EL | 1 |
| Saxena, V | 1 |
| Malt, L | 1 |
| Jones, P | 1 |
| Grevot, A | 1 |
| Poll, C | 1 |
| Osborne, C | 1 |
| Banner, KH | 1 |
| Kim, NY | 1 |
| Park, JS | 1 |
| Lee, KJ | 1 |
| Yun, HK | 1 |
| Kim, JS | 1 |
| Rianthavorn, P | 1 |
| Caliskan, B | 1 |
| Guven, A | 1 |
| Ozler, M | 1 |
| Cayci, T | 1 |
| Ozcan, A | 1 |
| Bedir, O | 1 |
| Surer, I | 1 |
| Korkmaz, A | 1 |
| Ulloa F, MT | 1 |
| Porte, L | 1 |
| Braun J, S | 1 |
| Dabanch P, J | 1 |
| Fica C, A | 1 |
| Henríquez A, T | 1 |
| Osorio A, CG | 1 |
| Lim, SK | 2 |
| Park, IW | 1 |
| Lee, WG | 1 |
| Kim, HK | 1 |
| Choi, YH | 1 |
| Hooton, TM | 2 |
| Roberts, PL | 1 |
| Stapleton, AE | 1 |
| Riaz, MM | 1 |
| Patel, MJ | 1 |
| Khan, MS | 1 |
| Anwar, MA | 1 |
| Tariq, M | 1 |
| Hilal, H | 1 |
| Awan, S | 1 |
| Razi, S | 1 |
| Shin, J | 1 |
| Kim, J | 1 |
| Wie, SH | 1 |
| Cho, YK | 1 |
| Shin, SY | 1 |
| Yeom, JS | 1 |
| Lee, JS | 1 |
| Kweon, KT | 1 |
| Lee, H | 1 |
| Cheong, HJ | 1 |
| Park, SH | 1 |
| Park, DW | 1 |
| Ryu, SY | 1 |
| Chung, MH | 2 |
| Yoo, S | 1 |
| Pai, H | 1 |
| Hooper, CY | 1 |
| Lightman, SL | 1 |
| Pacheco, P | 1 |
| Tam, PM | 1 |
| Khan, A | 1 |
| Taylor, SR | 1 |
| Hansson, J | 1 |
| Körner, U | 1 |
| Ludwigs, K | 1 |
| Johnsson, E | 1 |
| Jönsson, C | 1 |
| Lundholm, K | 1 |
| Pérez-Legaz, J | 1 |
| Serrano, P | 1 |
| Soriano-Irigaray, L | 1 |
| Sandberg, T | 1 |
| Skoog, G | 1 |
| Hermansson, AB | 1 |
| Kahlmeter, G | 1 |
| Kuylenstierna, N | 1 |
| Lannergård, A | 1 |
| Otto, G | 1 |
| Settergren, B | 1 |
| Ekman, GS | 1 |
| Blanco, JF | 1 |
| Pescador, D | 1 |
| Martín, JM | 1 |
| Cano, C | 1 |
| Sánchez, MD | 1 |
| Uchino, M | 1 |
| Ikeuchi, H | 1 |
| Matsuoka, H | 1 |
| Bando, T | 1 |
| Takesue, Y | 1 |
| Tomita, N | 1 |
| Okovityĭ, SV | 1 |
| Muzykin, MI | 1 |
| Iordanishvili, AK | 1 |
| Bakker-Woudenberg, IA | 1 |
| ten Kate, MT | 1 |
| Guo, L | 1 |
| Working, P | 1 |
| Mouton, JW | 1 |
| Gomez, L | 1 |
| Garau, J | 2 |
| Estrada, C | 1 |
| Marquez, M | 1 |
| Dalmau, D | 1 |
| Xercavins, M | 1 |
| Martí, JM | 1 |
| Estany, C | 1 |
| Duĭsenova, AK | 1 |
| Kurmanova, KB | 1 |
| Kurmanova, GM | 1 |
| Horcajada, JP | 2 |
| Vilana, R | 1 |
| Moreno-Martínez, A | 1 |
| Alvarez-Vijande, R | 1 |
| Bru, C | 1 |
| Bargalló, X | 1 |
| Buñesch, L | 1 |
| Martínez, JA | 1 |
| Mensa, J | 2 |
| Mateos, JJ | 1 |
| Lomena, F | 1 |
| Velasco, M | 1 |
| Ortega, M | 1 |
| Fuertes, S | 1 |
| Pons, F | 1 |
| Loussaief, C | 1 |
| Battikh, R | 1 |
| Louzir, B | 1 |
| M'saddek, F | 1 |
| Abdelhafidh, NB | 1 |
| Bahri, M | 1 |
| Mâalaoui, H | 1 |
| Ajmi, F | 1 |
| Othmani, S | 1 |
| Fogo, AB | 1 |
| Oguz, Y | 1 |
| Doganci, L | 1 |
| Bulucu, F | 1 |
| Can, C | 1 |
| Oktenli, C | 1 |
| Yenicesu, M | 1 |
| Vural, A | 1 |
| Lim, S | 1 |
| Alam, MG | 1 |
| Yli-Kerttula, T | 1 |
| Luukkainen, R | 1 |
| Yli-Kerttula, U | 1 |
| Möttönen, T | 1 |
| Hakola, M | 1 |
| Korpela, M | 1 |
| Sanila, M | 1 |
| Uksila, J | 1 |
| Toivanen, A | 1 |
| Norra, C | 1 |
| Skobel, E | 1 |
| Breuer, C | 1 |
| Haase, G | 1 |
| Hanrath, P | 1 |
| Hoff, P | 1 |
| Kamanin, EI | 1 |
| Trofimov, AE | 1 |
| Payen, S | 1 |
| Serreau, R | 1 |
| Munck, A | 1 |
| Aujard, Y | 1 |
| Aigrain, Y | 1 |
| Bressolle, F | 1 |
| Jacqz-Aigrain, E | 1 |
| Roland, PS | 2 |
| Anon, JB | 2 |
| Moe, RD | 1 |
| Conroy, PJ | 2 |
| Dupre, SJ | 2 |
| Krueger, KA | 1 |
| Potts, S | 2 |
| Hogg, G | 2 |
| Kreisler, LS | 1 |
| Reese, B | 2 |
| Talan, DA | 1 |
| Klimberg, IW | 1 |
| Nicolle, LE | 2 |
| Kowalsky, SF | 3 |
| Church, DA | 3 |
| Steiger, D | 1 |
| Bubendorf, L | 1 |
| Oberholzer, M | 1 |
| Tamm, M | 1 |
| Leuppi, JD | 1 |
| Ra, A | 1 |
| Tobe, SW | 1 |
| Jones, FR | 1 |
| Sanchez, JL | 1 |
| Meza, R | 1 |
| Batsel, TM | 1 |
| Burga, R | 1 |
| Canal, E | 1 |
| Block, K | 1 |
| Perez, J | 1 |
| Bautista, CT | 1 |
| Escobedo, J | 1 |
| Walz, SE | 1 |
| Panhotra, BR | 1 |
| Saxena, AK | 1 |
| Al-Mulhim, K | 1 |
| Dow, G | 1 |
| Rao, P | 1 |
| Harding, G | 1 |
| Brunka, J | 1 |
| Kennedy, J | 1 |
| Alfa, M | 1 |
| Olivera, ME | 1 |
| Bistoni, A | 1 |
| Anun, HE | 1 |
| Salinas, A | 1 |
| Manzo, RH | 1 |
| Dughera, L | 1 |
| Serra, AM | 1 |
| Battaglia, E | 1 |
| Tibaudi, D | 1 |
| Navino, M | 1 |
| Emanuelli, G | 1 |
| Kolyvanos Naumann, U | 1 |
| Käser, L | 1 |
| Vetter, W | 1 |
| Okazaki, K | 1 |
| Matsushita, M | 1 |
| Kawamata, S | 1 |
| Shimatani, M | 1 |
| Fujii, T | 1 |
| Gupta, K | 1 |
| Stamm, WE | 1 |
| McCulley, JP | 1 |
| Ernst, EJ | 1 |
| Ernst, ME | 1 |
| Hoehns, JD | 1 |
| Bergus, GR | 1 |
| Klimberg, I | 2 |
| Shockey, G | 1 |
| Ellison, H | 1 |
| Fuller-Jonap, F | 1 |
| Keating, K | 1 |
| Cyrus, P | 1 |
| Das, S | 1 |
| Goyal, R | 1 |
| Ramachandran, VJ | 1 |
| Gupta, S | 1 |
| Wyss Lustenberger, R | 1 |
| Nemes, G | 1 |
| Heuser, Y | 1 |
| Stolle, D | 1 |
| Piroth, HD | 1 |
| Nemes, P | 1 |
| Loendersloot, E | 1 |
| Branolte, JH | 1 |
| Bos, JC | 1 |
| Schultsz, C | 1 |
| Vandenbroucke-Grauls, CM | 1 |
| Speelman, P | 1 |
| Prins, JM | 1 |
| Pertel, PE | 1 |
| Haverstock, D | 1 |
| Rafalsky, V | 1 |
| Andreeva, I | 1 |
| Rjabkova, E | 1 |
| Dohar, J | 1 |
| Giles, W | 1 |
| Bikhazi, N | 1 |
| Carroll, S | 1 |
| Moe, R | 1 |
| Dupre, S | 1 |
| Wall, M | 1 |
| Stroman, D | 1 |
| Crenshaw, K | 1 |
| Leibovici, L | 1 |
| Paul, M | 1 |
| Cullen, M | 1 |
| Bucaneve, G | 1 |
| Gafter-Gvili, A | 1 |
| Fraser, A | 1 |
| Kern, WV | 1 |
| Uncu, H | 1 |
| Demiroğlu, YZ | 1 |
| Gül, U | 1 |
| Güvel, S | 1 |
| Turunç, T | 1 |
| Cokaloğlu, S | 1 |
| Arslan, H | 2 |
| Shah, PD | 1 |
| Deokule, JS | 1 |
| Borlenghi, E | 1 |
| Cattaneo, C | 1 |
| Capucci, MA | 1 |
| Pan, A | 1 |
| Quaresmini, G | 1 |
| Franco, F | 1 |
| Grazioli, L | 1 |
| Carosi, GP | 1 |
| Rossi, G | 1 |
| Peláez, N | 1 |
| Sánchez, J | 1 |
| Grandea, L | 1 |
| Pino Rivero, V | 1 |
| Pantoja Hernández, CG | 1 |
| González Palomino, G | 1 |
| Mora Santos, ME | 1 |
| Pardo Romero, G | 1 |
| Blasco Huelva, A | 1 |
| Choe, YM | 1 |
| Choe, W | 2 |
| Lee, KY | 1 |
| Ahn, SI | 1 |
| Kim, K | 1 |
| Cho, YU | 1 |
| Choi, SK | 1 |
| Hur, YS | 1 |
| Kim, SJ | 1 |
| Hong, KC | 1 |
| Shin, SH | 1 |
| Kim, KR | 1 |
| Woo, ZH | 1 |
| Alecsandru, D | 1 |
| Gestoso, I | 1 |
| Romero, A | 1 |
| Martinez, A | 1 |
| Garcia, A | 1 |
| Lobo, J | 1 |
| Yagüe, MR | 1 |
| Klausner, HA | 1 |
| Brown, P | 1 |
| Peterson, J | 3 |
| Kaul, S | 3 |
| Khashab, M | 3 |
| Fisher, AC | 2 |
| Kahn, JB | 3 |
| Fisher, A | 1 |
| Dybowski, B | 1 |
| Jabłońska, O | 1 |
| Radziszewski, P | 1 |
| Gromadzka-Ostrowska, J | 1 |
| Borkowski, A | 1 |
| Jha, AK | 1 |
| Singh, JB | 1 |
| Dutta, D | 1 |
| Soria, X | 1 |
| Bielsa, I | 1 |
| Ribera, M | 1 |
| Herrero, MJ | 1 |
| Domingo, H | 1 |
| Carrascosa, JM | 1 |
| Ferrándiz, C | 1 |
| Erdogan, H | 1 |
| Ekinci, MN | 1 |
| Hoscan, MB | 1 |
| Erdogan, A | 1 |
| Sung, JJ | 1 |
| Lyon, DJ | 1 |
| Suen, R | 1 |
| Chung, SC | 1 |
| Co, AL | 1 |
| Cheng, AF | 1 |
| Leung, JW | 1 |
| Li, AK | 1 |
| Wolfensberger, TJ | 1 |
| Körner, F | 1 |
| Lewis, DA | 1 |
| Pollock, LM | 1 |
| Randell, J | 1 |
| Wilson, P | 1 |
| Kopelman, PG | 1 |
| Bach, D | 1 |
| van den Berg-Segers, A | 1 |
| Hübner, A | 1 |
| van Breukelen, G | 1 |
| Cesana, M | 1 |
| Plétan, Y | 1 |
| Kaminski, N | 1 |
| Bogomolski, V | 1 |
| Stalnikowicz, R | 1 |
| Rosolen, A | 1 |
| Drigo, P | 1 |
| Zanesco, L | 1 |
| Sherman, O | 1 |
| Beizer, JL | 1 |
| Iravani, A | 2 |
| Tice, AD | 1 |
| McCarty, J | 2 |
| Sikes, DH | 1 |
| Nolen, T | 1 |
| Gallis, HA | 1 |
| Whalen, EP | 1 |
| Tosiello, RL | 2 |
| Heyd, A | 5 |
| Guibert, J | 1 |
| Doganov, N | 1 |
| Iarŭkov, A | 1 |
| Karag'ozov, I | 1 |
| Bozhilov, D | 1 |
| Diavolov, V | 1 |
| Usberti, M | 1 |
| Gazzotti, RM | 1 |
| Mileti, M | 1 |
| Brazzoli, A | 1 |
| Zucca, F | 1 |
| Depetri, G | 1 |
| Braga, B | 1 |
| Losio, R | 1 |
| Sánchez, C | 1 |
| García-Restoy, E | 1 |
| Bella, F | 1 |
| Freixas, N | 1 |
| Simó, M | 1 |
| Lite, J | 1 |
| Sánchez, P | 1 |
| Espejo, E | 1 |
| Cobo, E | 1 |
| Houston, S | 1 |
| Isaacson, SH | 1 |
| Carr, J | 1 |
| Rowan, AJ | 1 |
| Pfau, A | 1 |
| Sacks, TG | 1 |
| Kelman, GJ | 1 |
| Roland, GC | 1 |
| Beagley, MJ | 1 |
| Waite, NM | 1 |
| Johnson, MD | 1 |
| Webster, NR | 1 |
| Fong, IW | 1 |
| Mithöfer, K | 1 |
| Fernández-del Castillo, C | 1 |
| Ferraro, MJ | 1 |
| Lewandrowski, K | 1 |
| Rattner, DW | 1 |
| Warshaw, AL | 1 |
| Moi, H | 2 |
| Morel, P | 2 |
| Gianotti, B | 2 |
| Barlow, D | 2 |
| Phillips, I | 2 |
| Jean, C | 2 |
| Reece, RJ | 1 |
| Nicholls, AJ | 1 |
| Leow, YH | 1 |
| Chan, RK | 1 |
| Cheong, LL | 1 |
| Goh, CL | 1 |
| Nadarajah, M | 1 |
| Beckebaum, S | 1 |
| Bircher, J | 1 |
| Gallenkamp, H | 1 |
| Bailey, RR | 2 |
| Begg, EJ | 1 |
| Smith, AH | 1 |
| Robson, RA | 2 |
| Lynn, KL | 2 |
| Chambers, ST | 1 |
| Barclay, ML | 1 |
| Hornibrook, J | 1 |
| Frosco, MB | 1 |
| Melton, JL | 1 |
| Stewart, FP | 1 |
| Kulwich, BA | 1 |
| Licata, L | 1 |
| Barrett, JF | 1 |
| Kanga, JF | 1 |
| Kuhn, RJ | 2 |
| Rubio, TT | 2 |
| Spohn, WA | 1 |
| Stevens, JC | 1 |
| Painter, BG | 1 |
| Thurberg, BE | 1 |
| Haverstock, DC | 2 |
| Perroncel, RY | 1 |
| Echols, RM | 6 |
| Miles, MV | 1 |
| Lettieri, JT | 1 |
| Redmond, AO | 1 |
| Horowitz, HW | 1 |
| Holmgren, D | 1 |
| Seiter, K | 1 |
| Mantzaris, GJ | 2 |
| Archavlis, E | 2 |
| Christoforidis, P | 1 |
| Kourtessas, D | 2 |
| Amberiadis, P | 2 |
| Florakis, N | 1 |
| Petraki, K | 2 |
| Spiliadi, C | 1 |
| Triantafyllou, G | 2 |
| Karande, S | 1 |
| Kshirsagar, NA | 1 |
| Küchle, C | 1 |
| Abele-Horn, M | 1 |
| Menninger, M | 1 |
| Held, E | 1 |
| Heesemann, J | 1 |
| Segura Porta, F | 1 |
| Moreno, A | 1 |
| Serrate, G | 1 |
| Claramonte, X | 1 |
| Martos Rodríguez, A | 1 |
| Ribot, T | 1 |
| Sanfeliu, I | 1 |
| Jiménez de Anta, MT | 1 |
| Loran, OB | 1 |
| Pushkar', DIu | 1 |
| Tevlin, KP | 1 |
| Chodosh, S | 3 |
| Lakshminarayan, S | 1 |
| Swarz, H | 1 |
| Breisch, S | 1 |
| Klein, GL | 1 |
| Whalen, E | 1 |
| Pärssinen, O | 1 |
| Rummukainen, M | 1 |
| Joseph, EM | 1 |
| Sperling, NM | 1 |
| Hsieh, WJ | 1 |
| Lin, HC | 1 |
| Hwang, SJ | 1 |
| Hou, MC | 1 |
| Lee, FY | 1 |
| Chang, FY | 1 |
| Richard, GA | 1 |
| Klimberg, IN | 1 |
| Fowler, CL | 1 |
| Callery-D'Amico, S | 1 |
| Ahmed, A | 1 |
| Zuck, P | 1 |
| Weber, P | 1 |
| Farkas, S | 1 |
| Tosiello, R | 2 |
| Shan, M | 3 |
| Aneiro, L | 1 |
| Kowalsky, S | 1 |
| Caron, F | 1 |
| Prantera, C | 1 |
| Berto, E | 1 |
| Scribano, ML | 1 |
| Falasco, G | 1 |
| McCarty, JM | 1 |
| Richard, G | 1 |
| Huck, W | 2 |
| Tucker, RM | 1 |
| Goto, T | 1 |
| Kitagawa, T | 1 |
| Kawahara, M | 1 |
| Hayami, H | 1 |
| Ohi, Y | 1 |
| Clifford, K | 1 |
| Briefer, C | 1 |
| Munera, C | 1 |
| Destache, CJ | 1 |
| Dewan, N | 1 |
| O'Donohue, WJ | 1 |
| Campbell, JC | 1 |
| Angelillo, VA | 1 |
| Anzueto, A | 1 |
| Rizzo, JA | 1 |
| Grossman, RF | 1 |
| Read, RC | 1 |
| Kuss, A | 1 |
| Berrisoul, F | 1 |
| Kearsley, N | 1 |
| Kubin, R | 1 |
| Brazille, P | 1 |
| Coutant-Perronne, V | 1 |
| Malkin, JE | 1 |
| Raguin, G | 1 |
| Eickhoff, JH | 1 |
| Frimodt-Møller, N | 1 |
| Walter, S | 1 |
| Frimodt-Møller, C | 1 |
| Hans, W | 1 |
| Schölmerich, J | 1 |
| Gross, V | 1 |
| Falk, W | 1 |
| Irwin, PJ | 1 |
| Whithear, K | 1 |
| Lavelle, RB | 1 |
| Parry, BW | 1 |
| Leibovitz, E | 1 |
| Janco, J | 1 |
| Piglansky, L | 1 |
| Press, J | 1 |
| Yagupsky, P | 1 |
| Reinhart, H | 1 |
| Yaniv, I | 1 |
| Dagan, R | 1 |
| Mann, S | 1 |
| Thillainayagam, A | 1 |
| Join-Lambert, OF | 1 |
| Michéa-Hamzehpour, M | 1 |
| Köhler, T | 1 |
| Chau, F | 1 |
| Faurisson, F | 1 |
| Dautrey, S | 1 |
| Vissuzaine, C | 1 |
| Carbon, C | 1 |
| Pechère, J | 1 |
| Le Conte, P | 1 |
| Simon, N | 1 |
| Bourrier, P | 1 |
| Merit, JB | 1 |
| Lebrin, P | 1 |
| Bonnieux, J | 1 |
| Potel, G | 1 |
| Baron, D | 1 |
| Howarth, FH | 1 |
| Orlando, R | 1 |
| Mastrullo, L | 1 |
| De Blasi, D | 1 |
| Boffa, ML | 1 |
| Zorzato, G | 1 |
| Miraglia, E | 1 |
| Contreras, MA | 1 |
| Luna, R | 1 |
| Mulero, J | 1 |
| Andreu, JL | 1 |
| Christidou, A | 1 |
| Jaspers, CA | 1 |
| Begashaw, K | 1 |
| Shen, B | 1 |
| Achkar, JP | 1 |
| Lashner, BA | 1 |
| Ormsby, AH | 1 |
| Remzi, FH | 1 |
| Brzezinski, A | 1 |
| Bevins, CL | 1 |
| Bambrick, ML | 1 |
| Seidner, DL | 1 |
| Fazio, VW | 1 |
| Gaillat, J | 1 |
| Acheson, DW | 1 |
| Sears, CL | 1 |
| Takahashi, S | 1 |
| Hirose, T | 1 |
| Satoh, T | 1 |
| Kato, R | 1 |
| Hisasue, SI | 1 |
| Takagi, S | 1 |
| Shimizu, T | 1 |
| Kunishima, Y | 1 |
| Matsukawa, M | 1 |
| Itoh, N | 1 |
| Tsukamoto, T | 1 |
| Gomolin, IH | 1 |
| Siami, PF | 1 |
| Reuning-Scherer, J | 1 |
| Tripathi, A | 1 |
| Chen, SI | 1 |
| O'Sullivan, S | 1 |
| Kim, WH | 1 |
| Kim, S | 1 |
| Kan Ryu, J | 1 |
| Jin Kang, K | 1 |
| Suh, JK | 1 |
| Parisi, A | 1 |
| Filice, G | 1 |
| Marone, C | 1 |
| Quadri, F | 1 |
| Leigh, DA | 1 |
| Romanchuk, LA | 1 |
| Bush, V | 1 |
| Korshunov, VM | 1 |
| Peddie, BA | 1 |
| Smith, A | 1 |
| Marín Díez, JF | 1 |
| Botella Romero, F | 1 |
| Rojas Hidalgo, E | 1 |
| Gibb, AP | 1 |
| Lewin, CS | 1 |
| Garden, OJ | 1 |
| Karachalios, GN | 1 |
| Georgiopoulos, AN | 1 |
| Nasopoulou-Papadimitriou, DD | 1 |
| Adracta, DJ | 1 |
| Neill, MA | 1 |
| Opal, SM | 1 |
| Heelan, J | 1 |
| Giusti, R | 1 |
| Cassidy, JE | 1 |
| White, R | 1 |
| Mayer, KH | 1 |
| Thadepalli, H | 1 |
| Mathai, D | 1 |
| Scotti, R | 1 |
| Bansal, MB | 1 |
| Savage, E | 1 |
| Cain, DB | 1 |
| O'Connor, ME | 1 |
| Scarlini, GF | 1 |
| Germani, M | 1 |
| Martino, M | 1 |
| Perna, R | 1 |
| Raviglione, MC | 1 |
| Boyle, JF | 1 |
| Mariuz, P | 1 |
| Pablos-Mendez, A | 1 |
| Cortes, H | 1 |
| Merlo, A | 1 |
| Lang, R | 1 |
| Raz, R | 1 |
| Sacks, T | 1 |
| Shapiro, M | 1 |
| Maschmeyer, G | 1 |
| Daenen, S | 1 |
| de Pauw, BE | 1 |
| de Vries-Hospers, HG | 1 |
| Dekker, AW | 4 |
| Donnelly, JP | 1 |
| Gaus, W | 1 |
| Haralambie, E | 1 |
| Kern, W | 1 |
| Konrad, H | 1 |
| Mashilov, VP | 1 |
| Avdeeva, LA | 1 |
| Kaluzhina, TI | 1 |
| Brodov, LE | 1 |
| Golokhvastova, EL | 1 |
| Iakovleva, ON | 1 |
| Alikeeva, GK | 1 |
| Rozenberg-Arska, M | 4 |
| Verdonck, LF | 1 |
| Canton, P | 1 |
| Hoen, B | 1 |
| Richet, H | 1 |
| Ravoire, S | 1 |
| Acar, JF | 1 |
| Crombleholme, WR | 1 |
| Schachter, J | 1 |
| Ohm-Smith, M | 1 |
| Luft, J | 1 |
| Whidden, R | 1 |
| Sweet, RL | 1 |
| Apuzzio, JJ | 1 |
| Stankiewicz, R | 1 |
| Ganesh, V | 1 |
| Jain, S | 1 |
| Kaminski, Z | 1 |
| Louria, D | 1 |
| Heinonen, PK | 1 |
| Teisala, K | 1 |
| Miettinen, A | 1 |
| Aine, R | 1 |
| Punnonen, R | 1 |
| Grönroos, P | 1 |
| Abbas, AM | 1 |
| Chandra, V | 1 |
| Dongaonkar, PP | 1 |
| Goel, PK | 1 |
| Kacker, P | 1 |
| Patel, NA | 1 |
| Shrivastava, OP | 1 |
| Thakkar, B | 1 |
| Tillotson, GS | 1 |
| Hodson, ME | 1 |
| Roberts, CM | 1 |
| Butland, RJ | 1 |
| Smith, MJ | 1 |
| Batten, JC | 1 |
| Pichler, H | 2 |
| Diridl, G | 2 |
| Wolf, D | 2 |
| Tietgen, K | 1 |
| Schulz, E | 1 |
| Boness, J | 1 |
| Marre, R | 1 |
| Verhoef, J | 3 |
| Dekker, A | 1 |
| Møller, BR | 1 |
| Kaspersen, P | 1 |
| Mamsen, A | 1 |
| Korsager, B | 1 |
| Quitzau, K | 1 |
| Kosmidis, J | 1 |
| Gargalianos, P | 1 |
| Adamis, G | 1 |
| Petropoulou, D | 1 |
| Makris, D | 1 |
| Eugster, H | 1 |
| Eichmann, A | 1 |
| Stickler, K | 1 |
| Szarmach, H | 2 |
| Weuta, H | 2 |
| Podziewski, J | 2 |
| Skarzynski, J | 2 |
| Wronski, A | 2 |
| Nakamura, T | 1 |
| Hashimoto, I | 1 |
| Sawada, Y | 1 |
| Mikami, J | 1 |
| Bekki, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase III, Multicenter, Randomized, Double-Blind Clinical Trial to Assess the Efficacy and Safety of DF289 Plus DF277 Otic Solution Compared to DF289 Otic Solution and to DF277 Otic Solution in the Treatment of Acute Otitis Externa (AOE)[NCT03196973] | Phase 3 | 493 participants (Actual) | Interventional | 2017-07-22 | Completed | ||
| Conservative Treatment of Acute Appendicitis in Children Pilot Trial[NCT01572558] | 51 participants (Actual) | Interventional | 2012-02-29 | Completed | |||
| A Multicenter, Randomized, Double-Blind Clinical Trial to Assess the Efficacy and Safety of DF289 Plus DF277 Otic Solution Compared to DF289 Otic Solution and to DF277 Otic Solution in the Treatment of Acute Otitis Media With Tympanostomy Tubes (AOMT) in [NCT01404611] | Phase 3 | 331 participants (Actual) | Interventional | 2011-06-30 | Completed | ||
| Clinical Study to Assess the Efficacy and Safety of DF289 Plus DF277 Otic Solution in the Treatment of Middle Ear Infections in Pediatric Patients[NCT01395966] | Phase 3 | 331 participants (Actual) | Interventional | 2011-06-30 | Completed | ||
| Randomized Multicentric Controlled Clinical Trial of Parallel Groups to Evaluate the Non-therapeutic Inferiority of a Free Diet With a Progressive Diet, in the Treatment of Non-complicated Acute Diverticulitis[NCT03496090] | 134 participants (Actual) | Interventional | 2018-04-16 | Completed | |||
| Multicentre Controlled, Randomized Clinical Trial to Compare the Efficacy and Safety of Ambulatory Treatment of Mild Acute Diverticulitis Without Antibiotics With the Standard Treatment With Antibiotics[NCT02785549] | Phase 4 | 480 participants (Actual) | Interventional | 2016-11-30 | Completed | ||
| Cefpodoxime vs Ciprofloxacin for Acute Cystitis[NCT00194532] | 300 participants (Actual) | Interventional | 2005-06-30 | Completed | |||
| Controlling Antimicrobial Use Through Reducing Unnecessary Treatment of Catheter Associated Urinary Tract Infections (CARCUTI)[NCT02650518] | Phase 2/Phase 3 | 500 participants (Anticipated) | Interventional | 2015-12-31 | Recruiting | ||
| A Multicenter, Double-blind, Randomized Study to Compare the Efficacy and Safety of Levofloxacin 750 mg Once Daily for Five Days Versus Ciprofloxacin Twice Daily for Ten Days in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis[NCT00210886] | Phase 3 | 1,109 participants (Actual) | Interventional | 2004-10-31 | Completed | ||
| A Pilot Study of the Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis[NCT00583531] | Phase 2 | 2 participants (Actual) | Interventional | 2007-03-31 | Terminated (stopped due to Lack of enrollment) | ||
| Fecal Microbiota Transplantation for the Treatment of Chronic Pouchitis[NCT03538366] | 10 participants (Actual) | Interventional | 2018-05-15 | Completed | |||
| A Pilot Study of the Safety and Efficacy of AST-120 in the Treatment of Active Pouchitis[NCT00583076] | Phase 2 | 19 participants (Actual) | Interventional | 2007-02-28 | Completed | ||
| "A Phase 1b/2 Study to Demonstrate the Safety and Efficacy of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an Ileal Pouch-Anal Anastomosis (PROF). The PROF Study."[NCT05938465] | Phase 1/Phase 2 | 50 participants (Anticipated) | Interventional | 2023-10-11 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Therapeutic cure will be considered achieved if edema, otalgia and otorrhea are resolved with no further requirement of antimicrobial therapy and bacteriological response is Eradication or Presumed Eradication (NCT03196973)
Timeframe: End of Treatment (Day 8+2)
| Intervention | Participants (Count of Participants) |
|---|---|
| DF289 Plus DF277 | 63 |
| DF289 | 49 |
| DF277 | 20 |
First day on which there is no use of analgesics, the pain score is zero and remains zero until end of study (NCT03196973)
Timeframe: From baseline to End of Study (Day 15+2)
| Intervention | days (Median) |
|---|---|
| DF289 Plus DF277 | 5.0 |
| DF289 | 5.9 |
| DF277 | 7.7 |
(NCT01404611)
Timeframe: From baseline until the end of the study (up to 22 days)
| Intervention | days (Median) |
|---|---|
| DF289 | 6.83 |
| DF277 | 22 |
| DF289 Plus DF277 | 4.94 |
(NCT01395966)
Timeframe: From baseline until the end of the study ( up to 22 days)
| Intervention | days (Median) |
|---|---|
| DF289 | 7.69 |
| DF277 | 22 |
| DF289 Plus DF277 | 3.75 |
Participants with clinical cure, i.e. free of urinary tract symptoms and requiring no further antibiotic treatment, to assess the efficacy of a 3-day regimen of cefpodoxime compared to ciprofloxacin (NCT00194532)
Timeframe: 28-30 days post therapy
| Intervention | participants (Number) | |
|---|---|---|
| Cure | Not cure | |
| Cefpodoxime | 123 | 27 |
| Ciprofloxacin | 140 | 10 |
Elimination or decrease of causative uropathogen(s) in the mid-stream urine culture at follow-up (NCT00194532)
Timeframe: 1-15 days post therapy
| Intervention | participants (Number) | |
|---|---|---|
| Cure | Not cure | |
| Cefpodoxime | 104 | 25 |
| Ciprofloxacin | 123 | 5 |
15 reviews available for ciprofloxacin and Acute Disease
| Article | Year |
|---|---|
Comparative effectiveness and safety of antibiotic prophylaxis during induction chemotherapy in children with acute leukaemia: a systematic review and meta-analysis.
Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Chil | 2023 |
[Histoseminar on inflammatory bowel diseases (IBD): Case n
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Biopsy; Ciprofloxacin; Colon; Crohn Disease; Diagnosis, | 2017 |
A systematic review of randomised clinical trials for oral antibiotic treatment of acute pyelonephritis.
Topics: Acute Disease; Administration, Oral; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Drug Comb | 2018 |
Antimicrobial therapy of acute diarrhoea: a clinical review.
Topics: Acute Disease; Aminoglycosides; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Campyloba | 2016 |
Ciprofloxacin-related acute severe myalgia necessitating emergency care treatment: a case report and review of the literature.
Topics: Acute Disease; Anti-Bacterial Agents; Chronic Disease; Ciprofloxacin; Emergencies; Humans; Injection | 2009 |
[Diverticulitis (acute)/diverticulosis of the colon].
Topics: Acute Disease; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Diagnosis, Differential; | 2005 |
[Diagnosis and medical treatment of pouchitis in ileal pouch-anal anastomosis in patients with ulcerative colitis].
Topics: Acute Disease; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Humans; Immunologic Factor | 2005 |
[Optimising antibiotic policies in the Netherlands. IX. SWAB guidelines for antimicrobial therapy in adults with acute infectious diarrhoea].
Topics: Acute Disease; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Diarrhea; Dysentery; Erythromycin | 2006 |
Quinolones for uncomplicated acute cystitis in women.
Topics: Acute Disease; Adult; Anti-Infective Agents, Urinary; Ciprofloxacin; Cystitis; Female; Fluoroquinolo | 2006 |
Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions.
Topics: Acute Disease; Antibiotic Prophylaxis; Antineoplastic Agents; Bone Marrow Transplantation; Ciproflox | 2006 |
[Mycoplasma hominis. A rare causative agent of acute pyelonephritis].
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Doxycycline; Drug | 1997 |
[Current role of aminoglycosides in the treatment of acute pyelonephritis].
Topics: Acute Disease; Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cefadroxil | 1998 |
[Objectives for antibiotic therapy in acute exacerbations of chronic bronchitis].
Topics: Acute Disease; Adrenal Cortex Hormones; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; A | 2001 |
Use of quinolones for the treatment of acute exacerbations of chronic bronchitis.
Topics: Acute Disease; Anti-Infective Agents; Bronchitis; Chronic Disease; Ciprofloxacin; Fluoroquinolones; | 1991 |
Prevention of infection in acute leukemia.
Topics: Acute Disease; Anti-Bacterial Agents; Ciprofloxacin; Colistin; Drug Therapy, Combination; Humans; In | 1990 |
81 trials available for ciprofloxacin and Acute Disease
| Article | Year |
|---|---|
Efficacy and Safety of Ciprofloxacin Plus Fluocinolone Acetonide Among Patients With Acute Otitis Externa: A Randomized Clinical Trial.
Topics: Acute Disease; Administration, Topical; Adult; Anti-Bacterial Agents; Ciprofloxacin; Earache; Female | 2022 |
[Comparative assessment of Canephron N and ciprofloxacin as monotherapy of acute uncomplicated cystitis in women].
Topics: Acute Disease; Adolescent; Adult; Ciprofloxacin; Cystitis; Female; Humans; Middle Aged; Plant Extrac | 2018 |
Nonoperative treatment with antibiotics versus surgery for acute nonperforated appendicitis in children: a pilot randomized controlled trial.
Topics: Abdominal Pain; Acute Disease; Adolescent; Anti-Bacterial Agents; Appendectomy; Appendicitis; Child; | 2015 |
A New Approach to the Treatment of Uncomplicated Cystitis: Results of a Randomized Placebo-Controlled Clinical Trial.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Capsules; Ciprofloxacin; Cystitis; Double-Blind Method; | 2016 |
Efficacy and Safety of Ciprofloxacin Plus Fluocinolone in Otitis Media With Tympanostomy Tubes in Pediatric Patients: A Randomized Clinical Trial.
Topics: Acute Disease; Administration, Topical; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxaci | 2017 |
Efficacy and Safety of Ciprofloxacin Plus Fluocinolone in Otitis Media With Tympanostomy Tubes in Pediatric Patients: A Randomized Clinical Trial.
Topics: Acute Disease; Administration, Topical; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxaci | 2017 |
Efficacy and Safety of Ciprofloxacin Plus Fluocinolone in Otitis Media With Tympanostomy Tubes in Pediatric Patients: A Randomized Clinical Trial.
Topics: Acute Disease; Administration, Topical; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxaci | 2017 |
Efficacy and Safety of Ciprofloxacin Plus Fluocinolone in Otitis Media With Tympanostomy Tubes in Pediatric Patients: A Randomized Clinical Trial.
Topics: Acute Disease; Administration, Topical; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxaci | 2017 |
Topics: Acute Disease; Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Ciprofloxacin; C | 2017 |
Comparison of efficacy and safety of ciprofloxacin otic solution 0.2% versus polymyxin B-neomycin-hydrocortisone in the treatment of acute diffuse otitis externa*.
Topics: Acute Disease; Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial A | 2008 |
[Safety and efficiency of ambulatory treatment of acute diverticulitis].
Topics: Abdominal Pain; Abscess; Acute Disease; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Ambulatory C | 2009 |
A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease.
Topics: Acute Disease; Adult; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Double-Blind Method; Doxy | 2009 |
Outpatient treatment of patients with uncomplicated acute diverticulitis.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Ambulatory Care; Amoxicillin-Po | 2010 |
Comparison of safety and efficacy of foam-based versus solution-based ciprofloxacin for acute otitis externa.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Ciprofloxacin; Dosage Forms; F | 2010 |
Echinacea purpurea along with zinc, selenium and vitamin C to alleviate exacerbations of chronic obstructive pulmonary disease: results from a randomized controlled trial.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ascorbic Acid; Ciprofloxacin; | 2011 |
Cefpodoxime vs ciprofloxacin for short-course treatment of acute uncomplicated cystitis: a randomized trial.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Cefpodoxime; Ceftizox | 2012 |
Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Bacteriuria; Ciprofloxacin; Community-Acquired In | 2012 |
Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Arthritis, Reactive; Chronic Disease; Ciprofloxac | 2003 |
Topical ciprofloxacin/dexamethasone is superior to ciprofloxacin alone in pediatric patients with acute otitis media and otorrhea through tympanostomy tubes.
Topics: Acute Disease; Administration, Topical; Cerebrospinal Fluid Otorrhea; Child; Child, Preschool; Cipro | 2003 |
Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes.
Topics: Acute Disease; Administration, Topical; Anti-Infective Agents; Anti-Inflammatory Agents; Child; Chil | 2004 |
Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Del | 2004 |
A prospective, randomized trial of 3 or 14 days of ciprofloxacin treatment for acute urinary tract infection in patients with spinal cord injury.
Topics: Acute Disease; Adult; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Enterobacter | 2004 |
Ototopical ciprofloxacin in a glycerin vehicle for the treatment of acute external otitis.
Topics: Acute Disease; Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective A | 2004 |
Acute recurrent diverticulitis is prevented by oral administration of a polybacterial lysate suspension.
Topics: Acute Disease; Adjuvants, Immunologic; Administration, Oral; Aged; Analysis of Variance; Anti-Infect | 2004 |
Isolation of fluoroquinolone-resistant rectal Escherichia coli after treatment of acute uncomplicated cystitis.
Topics: Acute Disease; Adolescent; Adult; Ciprofloxacin; Cystitis; Drug Resistance, Bacterial; Escherichia c | 2005 |
Women's quality of life is decreased by acute cystitis and antibiotic adverse effects associated with treatment.
Topics: Acute Disease; Adult; Anti-Infective Agents, Urinary; Ciprofloxacin; Cystitis; Female; Humans; Middl | 2005 |
Time to symptom relief for uncomplicated urinary tract infection treated with extended-release ciprofloxacin: a prospective, open-label, uncontrolled primary care study.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Delayed-Action Prepara | 2005 |
Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes.
Topics: Acute Disease; Administration, Oral; Administration, Topical; Amoxicillin; Anti-Bacterial Agents; An | 2006 |
A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Double-Blind Method; Drug Administ | 2007 |
Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Ciprof | 2007 |
Ciprofloxacin and furagin in acute cystitis: comparison of early immune and microbiological results.
Topics: Acute Disease; Adult; Anti-Infective Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Cystitis | 2008 |
A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Do | 2008 |
A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Do | 2008 |
A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Do | 2008 |
A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Do | 2008 |
Intravenous ciprofloxacin as treatment for patients with acute suppurative cholangitis: a randomized, controlled clinical trial.
Topics: Acute Disease; Aged; Bacteria; Bile; Biliary Tract; Cholangitis; Ciprofloxacin; Double-Blind Method; | 1995 |
Rufloxacin once daily versus ciprofloxacin twice daily in the treatment of patients with acute uncomplicated pyelonephritis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anti-Infective Agents; C | 1995 |
Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Ciprofloxacin; Colony Count, Microbial; D | 1995 |
[Efficacy of single dose of ciprofloxacin and pefloxacin in the treatment of female acute cystitis].
Topics: Acute Disease; Administration, Oral; Adult; Ciprofloxacin; Cystitis; Double-Blind Method; Female; Hu | 1995 |
[The clinical study of the preparation ciprofloxacin in inflammatory gynecological diseases].
Topics: Acute Disease; Adult; Analysis of Variance; Chronic Disease; Ciprofloxacin; Endometritis; Female; Hu | 1993 |
Ciprofloxacin and trimethoprim-sulfamethoxazole versus placebo in acute uncomplicated Salmonella enteritis: a double-blind trial.
Topics: Acute Disease; Adult; Ciprofloxacin; Double-Blind Method; Drug Combinations; Enteritis; Feces; Femal | 1993 |
Single dose quinolone treatment in acute uncomplicated urinary tract infection in women.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Ciprofloxacin; Female; Gram-Negative Bacterial Infect | 1993 |
Efficacy and safety of single oral dose sparfloxacin vs ciprofloxacin in acute gonococcal urethritis in males. A multicentre international study.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Fluoroquinolones; G | 1995 |
Comparative efficacy and safety of single oral doses of sparfloxacin versus ciprofloxacin in the treatment of acute gonococcal urethritis in men.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Double | 1996 |
Comparing the efficacy of pefloxacin and ciprofloxacin in the treatment of acute uncomplicated gonococcal urethritis in males.
Topics: Acute Disease; Adolescent; Adult; Anti-Infective Agents; Anti-Infective Agents, Urinary; beta-Lactam | 1995 |
Bioavailability of ciprofloxacin in patients with acute infectious diarrhoe.
Topics: Acute Disease; Anti-Infective Agents; Area Under Curve; Bacterial Infections; Biological Availabilit | 1996 |
Prospective, randomized, controlled study comparing two dosing regimens of gentamicin/oral ciprofloxacin switch therapy for acute pyelonephritis.
Topics: Acute Disease; Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxa | 1996 |
Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group.
Topics: Acute Disease; Adolescent; Anti-Infective Agents; Arthralgia; Ceftazidime; Child; Child, Preschool; | 1997 |
Pharmacokinetic disposition of sequential intravenous/oral ciprofloxacin in pediatric cystic fibrosis patients with acute pulmonary exacerbation.
Topics: Acute Disease; Administration, Oral; Adolescent; Anti-Infective Agents; Biological Availability; Chi | 1997 |
Stepdown single agent antibiotic therapy for the management of the high risk neutropenic adult with hematologic malignancies.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciproflo | 1996 |
A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aminosalicylic Acids; Anti-Infective A | 1997 |
[Antibiotic treatment of acute gastroenteritis].
Topics: Acute Disease; Adolescent; Adult; Aged; Amdinocillin Pivoxil; Anti-Infective Agents; Ciprofloxacin; | 1997 |
[Experience with the use of ciprofloxacin in patients with acute uncomplicated cystitis].
Topics: Acute Disease; Adult; Anti-Infective Agents; Anti-Infective Agents, Urinary; Bacteriuria; Ciprofloxa | 1997 |
Efficacy and safety of a 10-day course of 400 or 600 milligrams of grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: comparison with a 10-day course of 500 milligrams of ciprofloxacin twice daily.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Bronch | 1998 |
Ciprofloxacin versus cefuroxime axetil in the treatment of adult patients with acute bacterial sinusitis.
Topics: Acute Disease; Adult; Aged; Analysis of Variance; Anti-Infective Agents; Cefuroxime; Cephalosporins; | 1998 |
The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding.
Topics: Acute Disease; Administration, Oral; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Fem | 1998 |
Levofloxacin versus ciprofloxacin versus lomefloxacin in acute pyelonephritis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Fem | 1998 |
Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
Topics: Acute Disease; Adolescent; Adult; Anti-Infective Agents; Bronchitis; Cefuroxime; Cephalosporins; Chr | 1998 |
A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Infective Agents, Urinary | 1999 |
Comparative study of single-dose and three-day therapy for acute uncomplicated cystitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Cefpodoxime Proxetil; Ceftizoxime; Ci | 1999 |
Double-blind comparative trial of ciprofloxacin versus clarithromycin in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infe | 1999 |
A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Infective Age | 1999 |
The efficacy and safety of a new ciprofloxacin suspension compared with co-amoxiclav tablets in the treatment of acute exacerbations of chronic bronchitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combina | 1999 |
[Ciprofloxacin and pivampicillin in acute epididymitis in men above the age of 40 years].
Topics: Acute Disease; Administration, Oral; Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Double-Blind | 2000 |
Oral ciprofloxacin vs. intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children.
Topics: Acute Disease; Administration, Oral; Adolescent; Anti-Infective Agents; Ceftriaxone; Cephalosporins; | 2000 |
[Acute pyelonephritis. Randomized multicenter double-blind study comparing ciprofloxacin with combined ciprofloxacin and tobramycin].
Topics: Acute Disease; Adult; Aged; Ciprofloxacin; Double-Blind Method; Drug Therapy, Combination; Escherich | 2001 |
A prospective randomized controlled trial of intravenous ciprofloxacin as an adjunct to corticosteroids in acute, severe ulcerative colitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Ciprofloxacin; Colitis, Ulcer | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
Efficacy and safety of ciprofloxacin oral suspension versus trimethoprim-sulfamethoxazole oral suspension for treatment of older women with acute urinary tract infection.
Topics: Acute Disease; Administration, Oral; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Infective | 2001 |
Comparison of ciprofloxacin with netilmicin for the treatment of acute pyelonephritis.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Ciprofloxacin; Escherichia coli Infect | 1992 |
Value of single-dose ciprofloxacin in the treatment of acute uncomplicated urinary tract infection in women.
Topics: Acute Disease; Adolescent; Adult; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; | 1991 |
Failure of ciprofloxacin to eradicate convalescent fecal excretion after acute salmonellosis: experience during an outbreak in health care workers.
Topics: Acute Disease; Adult; Carrier State; Ciprofloxacin; Convalescence; Disease Outbreaks; Double-Blind M | 1991 |
Ciprofloxacin monotherapy for acute pelvic infections: a comparison with clindamycin plus gentamicin.
Topics: Acute Disease; Adolescent; Adult; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Female; Gen | 1991 |
Failure of prolonged treatment with ciprofloxacin in acute infections due to Brucella melitensis.
Topics: Acute Disease; Adolescent; Adult; Brucellosis; Ciprofloxacin; Doxycycline; Female; Humans; Male; Mid | 1990 |
Prevention of infection in acute leukemia.
Topics: Acute Disease; Anti-Bacterial Agents; Ciprofloxacin; Colistin; Drug Therapy, Combination; Humans; In | 1990 |
Comparative efficacy of ciprofloxacin versus josamycin in the treatment of acute, recurrent, or exacerbated bronchitis.
Topics: Acute Disease; Bacteria; Bacterial Infections; Bronchitis; Ciprofloxacin; Humans; Josamycin; Microbi | 1989 |
Efficacy of single-agent therapy for the treatment of acute pelvic inflammatory disease with ciprofloxacin.
Topics: Acute Disease; Adult; Bacteria; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Female; Genta | 1989 |
Comparison of parenteral ciprofloxacin with clindamycin-gentamicin in the treatment of pelvic infection.
Topics: Acute Disease; Adult; Bacterial Infections; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; E | 1989 |
A comparison of ciprofloxacin with doxycycline plus metronidazole in the treatment of acute pelvic inflammatory disease.
Topics: Acute Disease; Adolescent; Adult; Bacterial Infections; Ciprofloxacin; Doxycycline; Drug Evaluation; | 1989 |
Ciprofloxacin versus amoxycillin/clavulanic acid in the treatment of urinary tract infections in general practice.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Ciprofloxacin; Clavulanic Ac | 1989 |
Oral ciprofloxacin compared with conventional intravenous treatment for Pseudomonas aeruginosa infection in adults with cystic fibrosis.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Azlocillin; Ciprofloxacin; Clinical Trials a | 1987 |
Ciprofloxacin in the treatment of acute bacterial diarrhea: a double blind study.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Campylobacter fetus; Campylobacter Infections; Ci | 1986 |
Therapy of acute and chronic gram-negative osteomyelitis with ciprofloxacin. Report from a Swedish Study Group.
Topics: Acute Disease; Administration, Oral; Arthritis; Bacterial Infections; Chronic Disease; Ciprofloxacin | 1988 |
Prevention of infection in patients with acute nonlymphocytic leukemia by several drug treatment regimens.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Clinical Trials as Topic; Colistin; Drug | 1987 |
Fleroxacin in single dose oral therapy of uncomplicated lower urinary tract infection.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Amoxicillin; Anti-Infective Agents; Ciproflo | 1988 |
Ciprofloxacin versus placebo in the treatment of acute bacterial diarrhea.
Topics: Acute Disease; Adult; Bacteria; Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Diarr | 1987 |
Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.
Topics: Acute Disease; Agranulocytosis; Bacterial Infections; Ciprofloxacin; Colistin; Drug Combinations; Dr | 1987 |
147 other studies available for ciprofloxacin and Acute Disease
| Article | Year |
|---|---|
Efficacy of fluoroquinolones against Leptospira interrogans in a hamster model.
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Ciprofloxacin; Cricetinae; Disease Models, Animal; Do | 2007 |
Synthesis and structure-activity relationships of new quinolone-type molecules against Trypanosoma brucei.
Topics: Acute Disease; Animals; Cell Line; DNA Topoisomerases, Type II; DNA, Kinetoplast; Mice; Microscopy, | 2012 |
Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis.
Topics: Acute Disease; Administration, Oral; Animals; Antitubercular Agents; Bacterial Proteins; Biological | 2014 |
Appropriateness of Antibiotic Prescribing for Acute Conjunctivitis: A Cross-Sectional Study at a Specialist Eye Hospital in Ghana, 2021.
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Child; Ciprofloxacin; Conjunctivitis; Cross | 2022 |
Acute Diarrheal Illness.
Topics: Acute Disease; Adolescent; Ciprofloxacin; Colon; Diarrhea; Feces; Female; Heart Rate; Humans; Ileum; | 2020 |
Acute hepatitis and pancytopenia related to non-typhoidal salmonella infection in a human immunodeficiency virus-infected patient.
Topics: Acute Disease; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Ciprofloxacin; Fatigue; | 2019 |
Antimicrobial Susceptibility of Campylobacter isolates in the Capital of North Macedonia.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter; | 2019 |
Acute Thyroiditis Associated with Brucellosis: A Case Report.
Topics: Acute Disease; Anti-Bacterial Agents; Arthritis; Brucellosis; Ciprofloxacin; Gentamicins; Humans; Ma | 2019 |
Practitioner Education and Feedback to Decrease Ciprofloxacin Prescriptions in Patients with Acute Uncomplicated Cystitis.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Ciprofloxacin; Cystitis; Drug Prescriptions; Female; Fo | 2020 |
Comparative study on the efficacy of non-steroidal, steroid and non-use of anti-inflammatory in the treatment of acute epidemic conjunctivitis.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Analysis of Variance; Anti-Inflamma | 2020 |
Primary Infectious Acute Pancreatitis: A 9 Case Series.
Topics: Acute Disease; Acyclovir; Adult; Anti-Bacterial Agents; Antiviral Agents; Bacterial Infections; Ceph | 2020 |
Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 2: Treatment.
Topics: Acute Disease; Advisory Committees; Algorithms; Anti-Bacterial Agents; Biological Products; Budesoni | 2020 |
Pyelonephritis.
Topics: Acute Disease; Adult; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Female; Fluid Therapy; Fluor | 2020 |
Controlled release of ciprofloxacin and ceftriaxone from a single ototopical administration of antibiotic-loaded polymer microspheres and thermoresponsive gel.
Topics: Acute Disease; Administration, Topical; Animals; Anti-Bacterial Agents; Ceftriaxone; Chinchilla; Cip | 2020 |
Identification of pathogens isolated in acute external otitis cases and evaluation of aminoglycoside and quinolone sensitivity.
Topics: Acute Disease; Administration, Topical; Adult; Age Factors; Amikacin; Aminoglycosides; Anti-Bacteria | 2021 |
[The complicated acute bacterial parotitis in adults].
Topics: Acute Disease; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefotaxi | 2017 |
A Cohort Study of Risk Factors That Influence Empirical Treatment of Patients with Acute Pyelonephritis.
Topics: Acute Disease; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ce | 2017 |
Ciprofloxacin otic suspension (Otiprio) for acute otitis externa.
Topics: Acute Disease; Administration, Topical; Anti-Bacterial Agents; Ciprofloxacin; Drug Approval; Humans; | 2018 |
Obstructive urosepsis secondary to ureteric herniation into the sciatic foramen.
Topics: Abdominal Pain; Acute Disease; Aged; Anti-Bacterial Agents; Ciprofloxacin; Female; Hernia; Humans; H | 2018 |
Unilateral acute dacryocystitis associated with oculoglandular tularemia: a case report.
Topics: Acute Disease; Adult; Amikacin; Anti-Bacterial Agents; Antibodies, Bacterial; Ciprofloxacin; Clavula | 2013 |
A comparison between doxycycline-rifampin and ciprofloxacin-rifampin regimens in the treatment of acute Brucellosis.
Topics: Acute Disease; Anti-Bacterial Agents; Brucellosis; Ciprofloxacin; Doxycycline; Drug Therapy, Combina | 2011 |
Bacteremia due to Aeromonas hydrophila in acute lymphoblastic leukemia.
Topics: Acute Disease; Aeromonas hydrophila; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Female; Fever | 2013 |
PrtR homeostasis contributes to Pseudomonas aeruginosa pathogenesis and resistance against ciprofloxacin.
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Bronchoalveolar Lavage | 2014 |
Factors associated with ciprofloxacin- and cefotaxime-resistant Escherichia coli in women with acute pyelonephritis in the emergency department.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Ba | 2014 |
Acute pancreatitis secondary to ciprofloxacin therapy in patients with infectious colitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infectio | 2014 |
Ciprofloxacin-induced tendinopathy of the gluteal tendons.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Buttocks; Ciprofloxacin; Female; Humans; Magnetic Reson | 2014 |
First report of Nocardia fusca isolated in humans.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Ciprofloxacin; Diagnosis, Differential; Humans; Male; No | 2015 |
Bloodstream bacterial infection among outpatient children with acute febrile illness in north-eastern Tanzania.
Topics: Acute Disease; Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Child; Child, Preschool; Chlorampheni | 2015 |
Empirical treatment in patients with acute obstructive pyelonephritis.
Topics: Acute Disease; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Escherichia coli; Female; Humans; | 2015 |
Microbiological Characteristics of Unresolved Acute Uncomplicated Cystitis.
Topics: Acute Disease; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ce | 2016 |
Significant increase of serum prostate-specific antigen after exercise.
Topics: Acute Disease; Ciprofloxacin; Exercise; Humans; Indoles; Male; Middle Aged; Prostate-Specific Antige | 2016 |
Acute isolated appendicitis due to Aspergillus carneus in a neutropenic child with acute myeloid leukemia.
Topics: Acute Disease; Acyclovir; Amphotericin B; Antifungal Agents; Appendicitis; Aspergillosis; Aspergillu | 2016 |
Outpatient treatment in uncomplicated acute diverticulitis: 5-year experience.
Topics: Acetaminophen; Acute Disease; Adult; Aged; Aged, 80 and over; Ambulatory Care; Analgesics, Non-Narco | 2016 |
Viral and Bacterial Etiology of Acute Diarrhea among Children under 5 Years of Age in Wuhan, China.
Topics: Acute Disease; Anti-Bacterial Agents; Azithromycin; Campylobacter; Child, Preschool; China; Ciproflo | 2016 |
Risk Factor Analysis of Ciprofloxacin-Resistant and Extended Spectrum Beta-Lactamases Pathogen-Induced Acute Bacterial Prostatitis in Korea.
Topics: Acute Disease; Adult; Age Factors; Aged; Amikacin; Anti-Bacterial Agents; Bacterial Infections; beta | 2016 |
[Acute myocarditis after visiting Pakistan].
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Anti-Infective Agents; C-Reactive Protein; Ceftriaxone; | 2008 |
[Acute group A beta-hemolytic streptococcus membranous laryngotracheobronchitis in an adult].
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; | 2008 |
[Acute dermohypodermitis of the right leg (S. putrefaciens) after sea bathing].
Topics: Acute Disease; Aged; Anti-Infective Agents; Ciprofloxacin; Humans; Leg Ulcer; Male; Oceans and Seas; | 2009 |
Differences in bacteriologic treatment failures in acute otitis externa between ciprofloxacin/dexamethasone and neomycin/polymyxin B/hydrocortisone: results of a combined analysis.
Topics: Acute Disease; Administration, Topical; Ciprofloxacin; Dexamethasone; Drug Therapy, Combination; Hum | 2009 |
Antibiotic prophylaxis in severe acute pancreatitis: do we need more meta-analytic studies?
Topics: Acute Disease; Antibiotic Prophylaxis; Carbapenems; Cefuroxime; Ciprofloxacin; Humans; Meta-Analysis | 2009 |
Auditory function after a prolonged course of ciprofloxacin-dexamethasone otic suspension in a murine model.
Topics: Acute Disease; Animals; Anti-Infective Agents; Ciprofloxacin; Dexamethasone; Disease Models, Animal; | 2009 |
A 'gap' between physician and patient assessment of symptom severity in acute cystitis?: a multicenter trial of women treated with extended-release ciprofloxacin.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Child; Ciprofloxac | 2004 |
Risk factors for urinary tract infections due to ciprofloxacin-resistant Escherichia coli in a tertiary care urology department in Switzerland.
Topics: Acute Disease; Aged; Anti-Infective Agents, Urinary; Bacteremia; Bacteriuria; Ciprofloxacin; Cross-S | 2010 |
Risk factors for antimicrobial resistance among the Escherichia coli strains isolated from Korean patients with acute uncomplicated cystitis: a prospective and nationwide study.
Topics: Acute Disease; Adolescent; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; | 2010 |
Antibiotic prescribing for adults with acute cough/lower respiratory tract infection: congruence with guidelines.
Topics: Acute Disease; Adult; Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Cough; Drug | 2011 |
Characterisation of a refined rat model of respiratory infection with Pseudomonas aeruginosa and the effect of ciprofloxacin.
Topics: Acute Disease; Agar; Animals; Anti-Infective Agents; Bacterial Load; Bronchoalveolar Lavage Fluid; C | 2011 |
[A case of acute phlegmonous gastritis causing gastroparesis and cured with medical treatment alone].
Topics: Acinetobacter; Acute Disease; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Ceftri | 2011 |
Progression and resolution of acute focal bacterial nephritis.
Topics: Acute Disease; Cefotaxime; Child, Preschool; Ciprofloxacin; Disease Progression; Drug Therapy, Combi | 2011 |
Ozone therapy prevents renal inflammation and fibrosis in a rat model of acute pyelonephritis.
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Aspartate Aminotransferases; Calcitonin; Ciprofloxaci | 2011 |
[Acute gastroenteritis caused by a Vibrio cholerae non-O1, non-O139 strain harboring a genetic region homologous to the VpaI-7 pathogenicity island].
Topics: Acute Disease; Anti-Infective Agents; Ciprofloxacin; Female; Gastroenteritis; Genomic Islands; Human | 2011 |
Change of antimicrobial susceptibility among Escherichia coli strains isolated from female patients with community-onset acute pyelonephritis.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Community-Acquired Infections; Dru | 2012 |
Clinical characteristics and predictors of positive stool culture in adult patients with acute gastroenteritis.
Topics: Acute Disease; Adult; Age Distribution; Campylobacter; Ciprofloxacin; Community-Acquired Infections; | 2012 |
Fluoroquinolone resistance in uncomplicated acute pyelonephritis: epidemiology and clinical impact.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escher | 2012 |
Adjunctive antibiotics in the treatment of acute bacterial endophthalmitis following cataract surgery.
Topics: Acute Disease; Administration, Oral; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Bacteria; | 2012 |
Antibiotics as first-line therapy for acute appendicitis: evidence for a change in clinical practice.
Topics: Acute Disease; Administration, Intravenous; Administration, Oral; Adult; Anti-Bacterial Agents; Appe | 2012 |
Applicability, safety and efficiency of outpatient treatment in uncomplicated diverticulitis.
Topics: Acetaminophen; Acute Disease; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anti-Infective Agents | 2012 |
Acute infection of total knee arthroplasty due to a cat scratch in a patient with rheumatoid arthritis.
Topics: Acute Disease; Aged, 80 and over; Animals; Anti-Infective Agents; Arthritis, Infectious; Arthritis, | 2012 |
Clinical features and management of pouchitis in Japanese ulcerative colitis patients.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Age of Onset; Aged; Anti-Bacterial Agents; Asian Peop | 2013 |
[The improvement of complex treatment of odontogenous periostitis in elderly patients].
Topics: Acute Disease; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacteria | 2012 |
Ciprofloxacin in polyethylene glycol-coated liposomes: efficacy in rat models of acute or chronic Pseudomonas aeruginosa infection.
Topics: Acute Disease; Animals; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Disease Progression; | 2002 |
Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteremia; Ciprofloxacin | 2003 |
[Ciprofloxacin in the treatment of patients with brucellosis].
Topics: Acute Disease; Adult; Antibody Formation; Brucella melitensis; Brucellosis; Chronic Disease; Ciprofl | 2002 |
Transrectal prostatic ultrasonography in acute bacterial prostatitis: findings and clinical implications.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Bacterial Infections; Ceftriaxone; Ciprofloxacin; | 2003 |
Diagnosis and follow-up of acute bacterial prostatitis and orchiepididymitis detected by In-111-labeled leukocyte imaging.
Topics: Acute Disease; Bacterial Infections; Ciprofloxacin; Epididymitis; Follow-Up Studies; Humans; Indium | 2003 |
[Myeloradiculoneuritis of Mycoplasma pneumoniae: a case report].
Topics: Acute Disease; Anti-Infective Agents; Anti-Inflammatory Agents; Ciprofloxacin; Drug Therapy, Combina | 2003 |
Quiz page. Diabetic nephropathy with superimposed acute interstitial nephritis.
Topics: Acute Disease; Aged; Aged, 80 and over; Basement Membrane; Biopsy; Ciprofloxacin; Creatinine; Diabet | 2003 |
Acute pyelonephritis causing acute renal allograft dysfunction.
Topics: Acute Disease; Anti-Infective Agents; Ciprofloxacin; Female; Graft Rejection; Humans; Kidney; Kidney | 2002 |
Ciprofloxacin-induced acute interstitial nephritis and autoimmune hemolytic anemia.
Topics: Acute Disease; Aged; Anemia, Hemolytic, Autoimmune; Anti-Infective Agents; Ciprofloxacin; Glucosepho | 2003 |
Ciprofloxacin-induced acute psychosis in a patient with multidrug-resistant tuberculosis.
Topics: Acute Disease; Adjuvants, Immunologic; Adult; Anti-Infective Agents; Ciprofloxacin; Female; Humans; | 2003 |
[Ciprofloxacin treatment of patients with acute and chronic otitis].
Topics: Acute Disease; Adult; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Female; Humans; Male; M | 2003 |
Population pharmacokinetics of ciprofloxacin in pediatric and adolescent patients with acute infections.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Bayes Theorem; Body Weight; Child; Child, Pr | 2003 |
Ciprofloxacin-induced acute interstitial pneumonitis.
Topics: Acute Disease; Aged; Anti-Infective Agents; Ciprofloxacin; Female; Humans; Lung Diseases, Interstiti | 2004 |
Acute interstitial nephritis due to pantoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Administration, Oral; Aged; Benzimidazoles; | 2004 |
Short report: High incidence of shigellosis among Peruvian soldiers deployed in the Amazon River basin.
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Ciprofloxacin; Diarrhea; Drug Resistance, B | 2004 |
Emergence of nalidixic acid resistance in Shigella sonnei isolated from patients having acute diarrheal disease: report from eastern province of Saudi Arabia.
Topics: Acute Disease; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Drug Resistance, Bacte | 2004 |
Low acute endophthalmitis rate: possible explanations.
Topics: Acute Disease; Anti-Infective Agents; Antibiotic Prophylaxis; Cataract Extraction; Ciprofloxacin; En | 2005 |
Fluoroquinolone resistance in Vibrio cholerae O1: emergence of El Tor Inaba.
Topics: Acute Disease; Anti-Infective Agents; Child; Cholera; Ciprofloxacin; Drug Resistance, Bacterial; Hum | 2005 |
[A young athletic man with dysuria and shivering].
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Ciprofloxacin; Diagnosis, Differential; Follow-Up Studi | 2005 |
Ciprofloxacin treatment of acute infections in immunocompromised host.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Clinical Tri | 1989 |
Efficacy and safety of ciprofloxacin in gynaecological infections.
Topics: Acute Disease; Administration, Oral; Anti-Infective Agents; Bacterial Infections; Chronic Disease; C | 1989 |
Risk factors for a poor outcome after therapy for acute pyelonephritis.
Topics: Acute Disease; Adolescent; Adult; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Diabetes | 2006 |
[A case of brucellosis presenting with urinary tract infection].
Topics: Acute Disease; Adult; Anti-Infective Agents; Brucella melitensis; Brucellosis; Ciprofloxacin; Humans | 2006 |
Isolation of Vibrio mimicus from a case of acute diarrhoea--a case report.
Topics: Acute Disease; Ciprofloxacin; Cities; Dysentery; Feces; Fluid Therapy; Humans; Male; Schools, Medica | 2006 |
Usefulness of the MSG/IFICG/EORTC diagnostic criteria of invasive pulmonary aspergillosis in the clinical management of patients with acute leukaemia developing pulmonary infiltrates.
Topics: Acute Disease; Adult; Aged; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Ciprofloxac | 2007 |
[Applicability, safety and efficacy of an ambulatory treatment protocol in patients with uncomplicated acute diverticulitis].
Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Ambulatory Care; Amoxicillin-Po | 2006 |
[Pseudomonas and acute external otitis. Results of a microbiological study in patients without previous antibiotic treatment].
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Age Factors; Aged; Anti-Bacterial Agents; An | 2007 |
Tc-99m ciprofloxacin imaging in acute cholecystitis.
Topics: Acute Disease; Adult; Aged; Cholecystitis; Ciprofloxacin; Female; Humans; Male; Middle Aged; Organot | 2007 |
E. coli multiresistant meningitis after transrectal prostate biopsy.
Topics: Acute Disease; Aged; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy; Ciprofloxaci | 2006 |
Microorganisms present in discharging otitis media in a group of patients in Kathmandu.
Topics: Acute Disease; Adolescent; Adult; Amikacin; Ciprofloxacin; Female; Gentamicins; Humans; Klebsiella p | 2007 |
Acute dermal abscesses caused by Serratia marcescens.
Topics: Abscess; Acute Disease; Adult; Ciprofloxacin; Humans; Male; Neutrophils; Serratia Infections; Serrat | 2008 |
Acute bacterial meningitis after transrectal needle biopsy of the prostate: a case report.
Topics: Acute Disease; Aged; Antibiotic Prophylaxis; Biopsy, Needle; Ceftriaxone; Ciprofloxacin; Diabetes Me | 2008 |
[Change in therapy of acute endophthalmitis: an analysis of 92 cases 1980-1993].
Topics: Acute Disease; Cataract Extraction; Ciprofloxacin; Combined Modality Therapy; Endophthalmitis; Follo | 1995 |
Acute gonococcal arthritis: an unusual host and pathogen combination.
Topics: Acute Disease; Aged; Arthritis, Infectious; Ciprofloxacin; Gonorrhea; Humans; Knee Joint; Male; Neis | 1995 |
Acute bacterial diarrhoea in the emergency room: therapeutic implications of stool culture results.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Bacterial Infections; Bacteri | 1994 |
Acute hemiparesis associated with ciprofloxacin.
Topics: Acute Disease; Adolescent; Ciprofloxacin; Cranial Nerve Diseases; Female; Hemiplegia; Humans; Precur | 1994 |
Possible ciprofloxacin-induced acute cholestatic jaundice.
Topics: Acute Disease; Aged; Aged, 80 and over; Cholestasis; Ciprofloxacin; Female; Humans | 1994 |
Treatment of acute peritonitis by temporary discontinuation of dialysis and low doses of oral ciprofloxacin in patients on CAPD.
Topics: Acute Disease; Administration, Oral; Bacterial Infections; Cefazolin; Ciprofloxacin; Clinical Protoc | 1994 |
Ciprofloxacin advertising in CMAJ.
Topics: Acute Disease; Advertising; Bronchitis; Chronic Disease; Ciprofloxacin; Drug Resistance, Microbial; | 1993 |
Ciprofloxacin-induced complex partial status epilepticus manifesting as an acute confusional state.
Topics: Acute Disease; Ciprofloxacin; Confusion; Humans; Male; Middle Aged; Status Epilepticus | 1993 |
Acute Pseudomonas infection following total hip replacement.
Topics: Acute Disease; Aged; Ciprofloxacin; Drug Delivery Systems; Hip Prosthesis; Humans; Male; Methylmetha | 1993 |
Poor response to oral ciprofloxacin in the treatment of peritonitis in patients on intermittent peritoneal dialysis.
Topics: Acute Disease; Administration, Oral; Ciprofloxacin; Female; Humans; Male; Microbial Sensitivity Test | 1993 |
Antibiotic treatment improves survival in experimental acute necrotizing pancreatitis.
Topics: Abscess; Acute Disease; Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Ciprofloxaci | 1996 |
Ciprofloxacin-induced acute interstitial nephritis.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Humans; Male; Middle Aged; Nephrit | 1996 |
In vivo efficacies of levofloxacin and ciprofloxacin in acute murine hematogenous pyelonephritis induced by methicillin-susceptible and-resistant Staphylococcus aureus strains.
Topics: Acute Disease; Animals; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Female; Kidne | 1996 |
Risk-benefit experience of ciprofloxacin use in pediatric patients in the United Kingdom.
Topics: Acute Disease; Anti-Infective Agents; Child; Ciprofloxacin; Humans; Joint Diseases; Pseudomonas Infe | 1997 |
Ciprofloxacin use: acute arthropathy and long-term follow up.
Topics: Acute Disease; Adverse Drug Reaction Reporting Systems; Anti-Infective Agents; Child; Child, Prescho | 1996 |
Acute glaucoma and acute corneal oedema in association with tularemia.
Topics: Acute Disease; Adrenergic beta-Antagonists; Anti-Infective Agents; Ciprofloxacin; Corneal Edema; Eye | 1997 |
Facial nerve paralysis in acute otitis media: cause and management revisited.
Topics: Acute Disease; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Age | 1998 |
Acute diverticulitis.
Topics: Acute Disease; Anti-Infective Agents; Ciprofloxacin; Diverticulitis, Colonic; Drug Therapy, Combinat | 1998 |
[The role of ciprofloxacin in the treatment of chronic bronchitis].
Topics: Acute Disease; Anti-Infective Agents; Bacterial Infections; Bronchitis; Chronic Disease; Ciprofloxac | 1998 |
[Bacteriology in community-acquired respiratory pathology].
Topics: Acute Disease; Ambulatory Care; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Ciprof | 1998 |
Use of antibiotics in the treatment of active Crohn's disease: experience with metronidazole and ciprofloxacin.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Cro | 1998 |
Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Bronchitis; Chronic Disease; Ciprofloxacin; Cost- | 1999 |
The infection-free interval: its use in evaluating antimicrobial treatment of acute exacerbation of chronic bronchitis.
Topics: Acute Disease; Bacterial Infections; Bronchitis; Cefuroxime; Ciprofloxacin; Clarithromycin; Humans; | 1999 |
[Agranulocytosis in acute hepatitis B in an HIV seropositive patient].
Topics: Acute Disease; Adult; Agranulocytosis; Anti-HIV Agents; Ciprofloxacin; Diagnosis, Differential; Drug | 2000 |
The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice.
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Biopsy; Body Weight; Chronic Disease; Ciprofloxacin; | 2000 |
Acute bronchopneumonia associated with Mycobacterium fortuitum infection in a dog.
Topics: Acute Disease; Animals; Anti-Infective Agents; Bronchopneumonia; Ciprofloxacin; Dog Diseases; Dogs; | 2000 |
Is ciprofloxacin a new cause of acute pancreatitis?
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Humans; Male; Pancreatitis | 2000 |
Differential selection of multidrug efflux mutants by trovafloxacin and ciprofloxacin in an experimental model of Pseudomonas aeruginosa acute pneumonia in rats.
Topics: Acute Disease; Animals; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Drug Resis | 2001 |
Acute pyelonephritis. A case discussion of primary care issues.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Female; Humans; Nurse Practitioners; Pri | 2000 |
Aeromonas sobria sepsis in a neutropenic patient.
Topics: Acute Disease; Aeromonas; Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxaci | 2001 |
Severe ciprofloxacin-induced acute hepatitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Chemical and Drug Induced Liver Injury; Ciprofloxacin; | 2001 |
Case report: an unusual presentation of Yersinia enterocolitica infection.
Topics: Acute Disease; Adult; Anti-Infective Agents; Biopsy; Ciprofloxacin; Colonoscopy; Diagnosis, Differen | 2001 |
Dangers of empiric oral ciprofloxacin in the treatment of acute inflammatory diarrhea in children.
Topics: Acute Disease; Anti-Infective Agents; Child; Child, Preschool; Ciprofloxacin; Diarrhea; Empiricism; | 2001 |
Efficacy of a 14-day course of oral ciprofloxacin therapy for acute uncomplicated pyelonephritis.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Drug Adminis | 2001 |
Acute psychosis following the use of topical ciprofloxacin.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Female; Humans; Ophthalmic Solutions; Ps | 2002 |
Imaging prostatitis with Tc-99m ciprofloxacin.
Topics: Acute Disease; Bacterial Infections; Chronic Disease; Ciprofloxacin; Humans; Male; Organotechnetium | 2002 |
Transverse myelitis associated with Mycoplasma pneumoniae pneumonitis: a report of two cases.
Topics: Acute Disease; Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Ciprofloxacin; Disease Suscep | 2001 |
Beware of ciprofloxacin in acute otitis media.
Topics: Acute Disease; Ciprofloxacin; Drug Resistance, Microbial; Humans; Male; Meningitis, Pneumococcal; Mi | 1992 |
The treatment of a large outbreak of acute bacterial gastroenteritis with ciprofloxacin.
Topics: Acute Disease; Ciprofloxacin; Disease Outbreaks; Female; Gastroenteritis; Humans; Male; Salmonella e | 1992 |
[Selective decontamination of the intestine and total gnotobiologic isolation in treatment of mice with acute radiation sickness].
Topics: Acute Disease; Amikacin; Animals; Ciprofloxacin; Decontamination; Germ-Free Life; Intestines; Mice; | 1992 |
[Ciprofloxacin in the ambulatory treatment of osteomyelitis in diabetic foot].
Topics: Acute Disease; Aged; Ambulatory Care; Ciprofloxacin; Diabetes Mellitus, Type 2; Diabetic Angiopathie | 1992 |
Development of quinolone resistance and multiple antibiotic resistance in Salmonella bovismorbificans in a pancreatic abscess.
Topics: Abscess; Acute Disease; Adult; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Hum | 1991 |
Pseudomembranous colitis associated with ciprofloxacin.
Topics: Acute Disease; Aged; Ciprofloxacin; Clostridioides difficile; Clostridium Infections; Drug Resistanc | 1990 |
Ciprofloxacin and pseudomembranous colitis.
Topics: Acute Disease; Ciprofloxacin; Clostridioides difficile; Contraindications; Diarrhea; Enterocolitis, | 1990 |
[Ciprofloxacin: a new fluoroquinolone for the treatment of respiratory tract infections].
Topics: Acute Disease; Adult; Aged; Ciprofloxacin; Female; Humans; Male; Middle Aged; Respiratory Tract Infe | 1991 |
Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Bacteriophage Typing; Ciprofloxacin; Drug Resista | 1990 |
[Experience in using new drug preparations for treating adult patients with acute intestinal infections].
Topics: Acute Disease; Adult; Anti-Infective Agents, Local; Carrier State; Ciprofloxacin; Drug Combinations; | 1990 |
Prevention of bacteremias caused by alpha-hemolytic streptococci by roxithromycin in patients treated with intensive cytotoxic treatment.
Topics: Acute Disease; Adult; Agranulocytosis; Amphotericin B; Antineoplastic Combined Chemotherapy Protocol | 1990 |
[Ciprofloxacin and cefotaxim: pharmacokinetic and therapeutic effectiveness in E. coli pyelonephritis in rats].
Topics: Acute Disease; Animals; Anti-Infective Agents, Urinary; Cefotaxime; Chronic Disease; Ciprofloxacin; | 1986 |
Fleroxacin in the treatment of uncomplicated acute cystitis in women.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Cystitis; Female; Fleroxacin; Follow-Up | 1988 |
Single dose therapy with Ro 23-6240 in patients suffering from acute, non-complicated gonococcal infection.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Fleroxacin; Gonorrhea; Humans; Male | 1987 |
Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora.
Topics: Acinetobacter; Acute Disease; Adult; Bacterial Infections; Bacteroides; Ciprofloxacin; Clostridium; | 1985 |
Acute respiratory insufficiency from psittacosis.
Topics: Acute Disease; Adult; Ciprofloxacin; Female; Humans; Middle Aged; Pneumonia; Psittacosis; Quinolines | 1985 |
Efficacy of a new quinolone in acute male gonorrhea.
Topics: Acute Disease; Ciprofloxacin; Gonorrhea; Humans; Male | 1987 |
Ciprofloxacin in acute male gonorrhea.
Topics: Acute Disease; Adult; Ciprofloxacin; Gonorrhea; Humans; Male | 1986 |
[Clinical evaluation of ciprofloxacin on biliary tract infection following oral administration].
Topics: Acute Disease; Administration, Oral; Adult; Aged; Cholecystitis; Cholelithiasis; Ciprofloxacin; Fema | 1986 |